Skip to content
AlternativeMed

Adaptogens · Herbs & Botanicals · Root used for tiredness, with weak evidence and a history of product mix-ups

Eleuthero

Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. (synonym Acanthopanax senticosus) · also called Siberian ginseng, eleuthero, Taigawurzel (German), ginseng siberiano (Spanish), ci wu jia (Chinese), Russian root

Eleuthero is a woody shrub from Northeast Asia. Its root is sold as 'Siberian ginseng', but it is not true ginseng. It is used for tiredness and stress. The evidence it works is weak: one trial in long-lasting fatigue found no difference from placebo overall, and the EU says no study proves benefit. The main safety points are product identity (past mix-ups with another plant, Periploca, that contains heart-active compounds), a possible effect on digoxin blood tests, and caution with blood pressure, diabetes and blood-thinning medicines, in pregnancy, breastfeeding and hormone-sensitive conditions.

General information, not medical advice. Last substantive update · Not medically reviewed. A named clinician has not signed off on this page. How this page is made

Get your Eleuthero today. Order now from Amazon and have it delivered to your door.Shop Eleuthero on AmazonSupport our free guides: as an Amazon Associate we earn from qualifying purchases.

About Eleuthero

Eleuthero (Eleutherococcus senticosus) is a shrub whose root is sold as 'Siberian ginseng'. It is used for tiredness, stress and endurance. The honest picture is that the evidence is weak: one trial in long-lasting tiredness found no overall difference from placebo, a trial in stress found no benefit when added to training, and exercise trials disagree. The EU allows it as a traditional medicine for tiredness and weakness based on long use but says no study proves benefit. Safety comes first: past products sold as pure Siberian ginseng were found to be mixed with Periploca, a plant with heart-active compounds. Some digoxin blood tests misread certain products. Sources disagree about blood pressure, blood sugar is uncertain, bleeding with some medicines has been reported, and it is not recommended in pregnancy, breastfeeding or under age 12. Ask a doctor or pharmacist about amounts.

What it is

Eleuthero is the root of Eleutherococcus senticosus, a woody shrub from Northeast Asia in the ginseng family (Araliaceae). Older papers and many Chinese sources call it Acanthopanax senticosus, a synonym. It is not true ginseng (Panax) and has different active compounds, mainly eleutherosides.

The root and rhizome are the traditional parts. Leaf, stem and fruit extracts also exist and have been tested separately, so results for one part should not be assumed for another.

49 51 27 25 34

What makes it distinctive

The word 'adaptogen' was coined in the Soviet Union in the 1960s by Brekhman, who studied this plant, according to the EU assessment report. The idea is that a substance helps the body resist many kinds of stress without upsetting normal function.

Its marker compounds are eleutherosides B and E. No single compound has been shown to explain its effects, and a review found the whole water extract the most potent for immune signals in the lab.

47 28 34

Historical and current uses

It is known in Chinese medicine as 'ci wu jia' and was studied heavily in the Soviet Union from the 1950s. A root extract was approved there in 1962 as a stimulant. It is used in France, Germany, Russia, the UK and China.

The EU recognises it as a traditional herbal medicine for symptoms of tiredness and weakness, in adults and adolescents over 12, based on long use. The EU's own review says the root does not reach well-established use because the clinical data are inconclusive.

47 48 46

What the research shows

The older Soviet-era studies were mostly small and uncontrolled. Among modern trials, one with 96 people found no difference from placebo for long-lasting tiredness overall, and one with 144 people found no extra benefit when added to stress training. Exercise trials disagree. The positive-looking results for colds, pneumonia, memory and burnout come from mixed products.

A 2025 review concluded that the trials are too different and too low in quality to judge effectiveness.

19 38 11 12 26 34 47

At a glance

Traditional uses history, not proof

  • Traditional Chinese, Korean and Japanese medicine: a tonic known as 'ci wu jia' for strength and stress resistance
  • Soviet Union from the 1960s: an extract approved in 1962 as a stimulant and used by athletes and workers; the term 'adaptogen' was coined for it
  • European use for decades in France, Germany, Russia and the UK as a tonic for tiredness
  • EU: recognised as a traditional herbal medicine for tiredness and weakness, based on long use only (adults and adolescents over 12)

Studied for research

  • Long-lasting tiredness and stress, very low certainty (one null trial; the EU says the evidence is inconclusive)
  • Exercise and endurance, mixed (two null trials, one small positive)
  • Coughs, colds and pneumonia recovery, very low or insufficient (only in mixed products)
  • Blood sugar, blood pressure, cholesterol, bone, hangover and swelling, very low or insufficient
  • Mood and thinking, insufficient (mixed products or no placebo)

Main compounds

  • Eleutheroside B (syringin) and eleutheroside E: marker compounds used to identify and standardise the root
  • Isofraxidin (a coumarin) and chlorogenic acid
  • Triterpene saponins and polysaccharides
  • The root, rhizome and bark are medicinal parts; leaf and fruit extracts have been tested separately

Common forms

  • Root, in forms recognised by the EU monograph (teas, powders, liquid and dry extracts, tinctures)
  • Mixed products: Kan Jang (with Adhatoda and Echinacea), ADAPT-232/Chisan (with Rhodiola and Schisandra), others; their results cannot be credited to eleuthero alone
  • Fruit and leaf extracts used in a few trials are different plant parts
  • Beware products labelled only 'ginseng': check for the species name and the root

Research links: EMA herbal page: Eleutherococci radix · EU herbal monograph on Eleutherococcus root (EMA, 2014) · EU assessment report on Eleutherococcus root (EMA) · Research Library · Genes & Biomarkers Library

The plant and its history

Accepted scientific name
Eleutherococcus senticosus (Rupr. & Maxim.) Maxim.
Naming authority
(Rupr. & Maxim.) Maxim., published in Mem. Div. Sav. Acad. Sci. St.-Petersb. 9: 132 (1859) (GBIF). Accepted (GBIF key 3035369; NCBI taxid 82096).
Synonyms
Acanthopanax senticosus (Rupr. & Maxim.) Harms (still widely used, especially in Chinese and Japanese literature); Hedera senticosa Rupr. & Maxim.; Eleutherococcus senticosus f. inermis Kom.; Eleutherococcus senticosus var. subinermis Regel; Acanthopanax senticosus var. brevistamineus S.F.Gu
Common names
Eleuthero (English); Siberian ginseng (English); Devil's bush (English); Taigawurzel (German); Ginseng siberiano (Spanish); Jinsém-siberiano (Portuguese); Russian root (rysk rot, russisk rot) (Swedish / Norwegian); Ci wu jia (刺五加) (Chinese); Ezo-ukogi (エゾウコギ) (Japanese); Gasiogalpi (가시오갈피) (Korean); Элеутерококк колючий (Russian)
Botanical family
Araliaceae (the ivy and ginseng family, order Apiales). The true ginsengs (Panax) are in the same family but are a different genus; LactMed says eleuthero is not related to true ginseng and has different constituents.
Classification
Plantae > Tracheophyta > Magnoliopsida > Apiales > Araliaceae > Eleutherococcus > Eleutherococcus senticosus
Native range
A 2025 review says it is native to Northeast Asia (not checked against a flora).
Habitat
Not verified in a source read.
What the plant looks like
Roots: The dried root, and underground parts (rhizome), are the part used in medicine (EMA). Stem bark, stems, leaf and fruit are used in some products and studies, with their own research.; Stems: Not verified from a source read. The name 'senticosus' means thorny; prickly stems are not described in the sources read.; Leaves: Leaf extracts were tested in one human trial (Tohda 2020); not the usual medicinal part.; Flowers: Not verified.; Fruit: Fruit extracts have been tested in a trial of blood pressure (Oh 2020).; Cultivation: Not verified.; Harvest processing: Not verified. The EMA lists the preparations (comminuted root, powder, liquid and dry extracts, tincture, wine extracts) recognised in the monograph.
Cultivation
A 2025 review says the plant is endangered in some areas and calls for sustainable cultivation.
Harvest and processing
Not verified in a source read.
Look-alikes and adulterants
Name: Periploca sepium Bunge (Chinese silk vine); Note: Different family (Apocynaceae, GBIF key 5526185). The EMA report says it contains cardiac glycosides and was found as an adulterant in a product sold as 'pure Siberian ginseng', linked to a newborn case and possibly to a digoxin case. Avoid products that cannot show species identity.; Name: Other Eleutherococcus species; Note: In a UK DNA test, 36% of 25 Siberian ginseng supplements contained another Eleutherococcus species as well as E. senticosus.; Name: Panax ginseng, Panax quinquefolius; Note: True ginseng, a different genus with ginsenosides. Eleuthero is not true ginseng, and the name 'Siberian ginseng' is confusing.
Sustainability and conservation
A 2025 review says the plant is endangered in some areas. No IUCN assessment was retrieved.

Traditional use and history history, not clinical proof

Tradition or eraDocumented useSource
Traditional Chinese, Korean and Japanese medicineUsed as 'ci wu jia' (Chinese). A 2025 review says it is used in traditional Chinese, Korean and Japanese medicine as an adaptogen for stress resistance, endurance and immune strength. A 2021 review adds invigorating the liver and kidneys, strengthening bones, stimulating appetite and improving memory. One review calls it a traditional medicine for twenty centuries; this was not checked against a primary source.p40572479
Soviet Union, 1950s to 1980sThe EMA report dates papers back to 1957 and the first article by Brekhman to 1960, and says over 1,000 articles have appeared. In 1962 a root extract was approved in the former Soviet Union as a 'stimulant', and in 1966 it was recommended for the Soviet space programme. Brekhman published the first book in 1968 and coined the term 'adaptogen'.s-ema-hmpc-eleutherococcus-radix-ar
Europe, 20th century to nowThe report says root preparations have been in medicinal use in France, Germany (products notified before January 1978), Russia, the UK and China. Names used in EU languages include Taigawurzel (German) and Russian root.s-ema-hmpc-eleutherococcus-radix-ar
European Union regulationRecognised as a traditional herbal medicine for symptoms of asthenia such as fatigue and weakness, based on long-standing use, for adults and adolescents over 12. The monograph was first adopted on 8 May 2008 and revised on 25 March 2014. The EMA states the root does not reach well-established use because clinical data are inconclusive.s-ema-hmpc-eleutherococcus-radix-monograph
NamingThe first English name 'Eleuthero' was created in the USA (Baranov, 1979); 'Siberian ginseng' has been used there since 1971 (both per the EMA report). LactMed says it is not related to true ginseng and has different constituents.s-ema-hmpc-eleutherococcus-radix-ar

Traditional use shows how a plant was used. It does not show that a supplement works or is safe today.

What is inside, and how it may work

What the plant contains and how those compounds act in cells and animals. Laboratory and animal mechanisms are not proven effects in people.

Main compounds

CompoundFamilyWhere it is concentratedActivity studiedLevel of evidence
Eleutheroside B (syringin)
PubChem 5316860
phenylpropanoid glycosideroot
About 0.5% of the root (EMA report)
A marker compound. Patyra 2025 says syringin helps tell E. senticosus from other Araliaceae plants. Lab work links it to adaptogenic action; not shown in people. 34 47 53Laboratory research
Eleutheroside E (syringaresinol diglucoside)
PubChem 71312557
lignan glycosideroot
About 0.1% (EMA report)
A marker compound. Activated a vessel receptor (Tie2) in lymphatic cells in the lab; reviewed as important in the adaptogenic response. 34 13 47 53Laboratory research
Isofraxidin (with eleutheroside B1)
PubChem 5318565
coumarinroot
Not given
Modulated immune function in lab studies. 28 47 53Laboratory research
Chlorogenic acid and caffeic acid derivatives
PubChem 1794427
phenolic acidroot
Chlorogenic acid up to 0.3% (EMA report)
Caffeoylquinic acids are among the main constituents according to Patyra 2025. 34 47 53Laboratory research
Sesamin (eleutheroside B4)
PubChem 72307
lignanroot
About 0.023% (EMA report)
No specific activity read. 47 53Laboratory research
Beta-hederin (eleutheroside K)
PubChem 441929
triterpene saponinroot
Not given
A saponin listed by the EMA report. No activity read. 47 53Laboratory research
Daucosterol (eleutheroside A, sitogluside)
PubChem 5742590
sterol glycosideroot
Not given
Listed by the EMA report. No activity read. 47 53Laboratory research
Coniferaldehyde and its glucoside
PubChem 5280536
phenylpropanoidroot
Not given
Listed by the EMA report. No activity read. 47 53Laboratory research
Polysaccharides (eleutherans, heteroglycans)polysaccharideroot
Not given
Polysaccharide-rich extracts were used in a hangover trial; water extract was the most potent for immune signals in a review. 47 28Laboratory research

Mechanisms, receptors and pathways

Target or pathwayGene or receptorWhat was foundLevel
Inflammation and immune signallingMAPK, Akt, NF-kBPatyra 2025 says preclinical studies show root extract inhibits MAPK, Akt and NF-kB activation, linked to anti-inflammatory and immune-modulating effects. Lab and animal findings only; not shown in people. 34Laboratory research
Nerve growth factorBDNFPer the same review, preclinical studies show an increase of brain-derived neurotrophic factor, which may contribute to stress and fatigue reduction and memory effects. Not shown in people. 34 29Animal research
Immune cell signalsCytokines from human blood cellsIsofraxidin, syringin and eleutheroside E modulated immune function in lab tests; the whole aqueous extract was the most potent, and the authors compared cytokine release from human blood cells. 28Laboratory research
Lymph vessel stabilisationTie2 receptor; eNOS; VE-cadherinSiberian ginseng and eleutheroside E triggered Tie2 phosphorylation in lymphatic cells and made vessel cells migrate and form cords. In 50 healthy women, a single serving reduced lower-leg swelling at 2 and 4 hours. 13Laboratory research
Stress-hormone receptorsGlucocorticoid, mineralocorticoid and oestrogen receptorsThe EMA report describes a 30% ethanol root extract binding oestrogen receptors in rat uterus and mineralocorticoid and glucocorticoid receptors in rat kidney in vitro, not androgen receptors, and raising corticosterone in rats given an extract by injection. 47Animal research
Stress-hormone breakdown (idea)COMTA theory paper proposes the root may inhibit the enzyme COMT, giving a two-way effect on stress responses. Not tested in that paper. 15Preliminary mechanism
Human stress-hormone indicesCortisol, testosteroneIn athletes, a 6-week extract lowered the testosterone-to-cortisol ratio (28.7%, P = 0.03) with a non-significant 31% cortisol rise. This is a human finding and went against the hoped-for direction. 14Human data
Drug transportP-glycoprotein, peptide transporterIn human gut-lining cells the extract suppressed P-glycoprotein and a peptide transporter and increased digoxin passage. Cell data only. 42Laboratory research
Drug-metabolising enzymes (human)CYP2D6, CYP3A4No effect in 12 healthy volunteers. 10Human data
Drug-metabolising enzymes (rat)CYP2C9, CYP2E1Isolated eleutherosides B and E weakly inhibited CYP2C9 and CYP2E1 in rat liver microsomes; no effect on CYP2D6 or CYP3A4. 18Laboratory research

Absorption, metabolism and elimination

Absorption
No human blood-level data for eleutheroside B or E were found in the sources read.
Distribution
Not established in humans.
Metabolism
Not established in humans. In rat blood, eleutheroside E showed enterohepatic circulation after an oral aqueous extract (cited in the EMA report; original not read).
Elimination
In rats given 3H-labelled eleutheroside B by injection, the blood peak was at 15 minutes, then fell sharply by 4 hours; about 90% was excreted in urine within 48 hours versus up to 3% in faeces (EMA report citing ESCOP). Rat data only.
Bioavailability
Not established in humans.

47 10

Isolated compounds versus whole extracts

No single compound has been shown to explain the effects. Eleutherosides B and E are used as marker compounds to standardise products. A 2019 lab review found the whole water extract was more potent than the single compounds for immune signalling, and argued for water extracts. The 2025 review says the lack of standard preparations makes trial results hard to compare.

Nutritional composition

A nutrient table is not meaningful for the medicinal use of the root.

22benefits and uses looked at
53studies and sources checked
Very low certaintybest evidence rating found
13lab markers tracked in trials

2 mixed findings3 very low certainty16 not enough evidence1 evidence against

What was looked at

The 22 benefits and uses checked for Eleuthero, each with how strong the evidence is. Tap one to open it.

Lab markers tracked in the studies

Cortisol (stress hormone)Testosterone-to-cortisol ratioHeart rate variability (CVRR, HF, LF/HF)Antioxidant-to-oxidant ratio (BAP/d-ROMs)Oxygen use at peak effort (VO2 peak)Time to exhaustionBlood glucoseSystolic blood pressureOsteocalcin (bone-turnover marker)Bone mineral density (DXA scan)C-reactive protein (CRP)Immune cell counts (T-cells, NK cells, B-cells)Total cholesterol, LDL and triglycerides

What is Eleuthero good for?

The main proposed uses and how strong the human evidence is for each. 'Mixed' means trials disagree, and 'very low' and 'insufficient' mean few, small, uncontrolled or mixed-product studies. None of these is a proven treatment for you. Many ratings are this profile's own reading, not formal grades. Several positive results come from mixed products or from the fruit or leaf, and are marked. Ask a doctor or pharmacist about amounts.

Long-lasting unexplained tirednessVery low certaintyOne US trial of 96 people with tiredness for six months or more found Siberian ginseng root extract did not beat placebo overall. A hint of benefit in people with less severe tiredness was an extra look at subgroups and cannot be relied on. The EU accepts the root as a traditional medicine for tiredness and weakness, but its own assessment says no study proves it works. Stress-related tiredness and burnoutNot enough evidenceA German trial of 144 people found that adding root extract to a stress-management course gave no extra benefit, and everyone improved over time. A French trial of a four-ingredient product that included Eleutherococcus found more improvement than placebo in burnout scores, but the result cannot be credited to Eleutherococcus alone. Quality of life in older peopleNot enough evidenceA trial of 20 older people on heart medicine found a better social-functioning score after 4 weeks, which was gone by 8 weeks. It is far too small to count on. Attention and memory tests (in mixed products)Not enough evidenceOne-dose and 12-week trials of mixes found small gains on some tests. One used a three-herb product; the other used the leaf (not the root) with a second herb. Neither shows what Eleutherococcus root does by itself. Mood: added to lithium in bipolar disorderNot enough evidenceA Chinese trial of 76 teenagers on lithium found the herb did about the same as fluoxetine, with no placebo group. This does not show the herb works. Bipolar disorder needs a specialist. Cancer-related tirednessNot enough evidenceA very small feasibility study: only 7 of 15 patients finished 28 days. Nothing can be concluded. Stress physiology in older adults (heart rate variability)Not enough evidenceA small Japanese trial of a related-species supplement found better heart-rate-variability readings after 4 weeks. It is a lab measure, the group was only 28 people, and the supplement maker's staff were involved. Stress hormones in athletesNot enough evidenceIn endurance athletes a 6-week extract lowered the testosterone-to-cortisol ratio, and cortisol tended to rise. That is the opposite of what an 'anti-stress' herb is meant to do, although the cortisol change was not statistically significant. Exercise and enduranceMixed findingsTwo small trials in trained athletes found no benefit. A trial of 9 men found about 12% higher oxygen capacity and 23% longer time to exhaustion. The results conflict and all trials are very small. Coughs, colds and pneumonia recovery (in mixed products)Very low certaintyTrials of three-herb mixes (Kan Jang and Chisan) found faster cough relief and 2 days less antibiotic treatment in pneumonia. They are mixes, so the result cannot be credited to Eleutherococcus. Immune cell numbers and 'immune support'Evidence againstIn a controlled trial in athletes, immune cell counts did not change. Lab studies suggest effects on immune signals, but no trial shows fewer infections from Eleutherococcus alone. Fever attacks in children with Familial Mediterranean Fever (in a four-herb mix)Not enough evidenceA pilot of 24 children found fewer severe attacks with a mix that also contained licorice. It cannot be credited to Eleutherococcus. Blood sugarNot enough evidenceIn 12 healthy people, Siberian ginseng raised blood sugar after a sugar drink; in one exercise trial blood sugar was lower. No trial in people with diabetes was found. People on diabetes medicine should be careful. Blood pressureMixed findingsResults are mixed: no change in trials in older adults, a drop with a fruit extract, a rise in a very old Russian child study, and one review that lists it among supplements that raise blood pressure. Cholesterol and blood fatsNot enough evidenceOne study with no placebo group reported changes in cholesterol and triglycerides after 30 days but the summary does not say in which direction. Bone health after menopauseVery low certaintyIn 81 postmenopausal women, a bone marker rose after 6 months, but bone density did not change. HangoverNot enough evidenceA small crossover trial of a polysaccharide-rich extract found milder hangover symptoms, but numbers were not available. Leg swellingNot enough evidenceOne crossover study of 50 healthy women found less lower-leg swelling at 2 and 4 hours. The authors work for a cosmetics company. Female sexual function (in a mixed supplement)Not enough evidenceA vitamin E and two-ginseng supplement improved desire and satisfaction scores but not the total score. Siberian ginseng cannot be credited.

Benefits, one by one

Each card is a research question, not a promise. Tap a goal to filter. Open a card to see the studies, doses and limits.

Long-lasting unexplained fatigue

Very low certainty

In one US trial of 96 people with fatigue for six months or more, Siberian ginseng did not beat placebo overall. A hint of benefit in people with less severe fatigue was an exploratory finding.

3 studiesStandardised root extract in the trial; products differ a lot.

Studies, doses and limits

What the trials found

One randomised placebo-controlled trial (Hartz 2004, 96 people, 2 months) found fatigue fell a lot in both groups with no significant difference overall. Pre-planned subgroup analyses suggested a benefit at 2 months in 45 people with less severe fatigue (P = 0.04, unadjusted for multiple comparisons). The 2025 review by Patyra and colleagues says the clinical trials are too different and too poor in quality to judge effectiveness. The EMA assessment concluded none of the studies is enough to prove efficacy in a clearly defined condition.

Results

No overall benefit over placebo; a subgroup hint only.

Effect sizes as reported

Overall difference not significant; subgroup P = 0.04 unadjusted.

Why this rating

One modest trial with a null main result and an exploratory subgroup finding; reviewers call the evidence inconclusive.

Form and dose studied

Standardised root extract in the trial; products differ a lot.

Who was studied

Adults with fatigue of 6 months or more and no known cause.

Limits

Single trial; about 20% of people did not give 2-month data; subgroup result is not reliable.

Why researchers looked

Fatigue and weakness are the main traditional uses and the uses the EU accepts for the root.

Traditional use

Eleutherococcus root has been used in Soviet-era and later European medicine as a tonic for tiredness and weakness, and in traditional Chinese medicine as 'ci wu jia'. The EU recognises it as a traditional herbal medicine for symptoms of asthenia (tiredness and weakness) based on long use, not on proof from trials.

Proposed mechanism Preliminary mechanism

Lab and animal work suggests eleutherosides and other root compounds may influence stress-hormone signalling and inflammation pathways. The EMA report notes that an extract raised corticosterone in rats and bound several hormone receptors in rat tissue in vitro. None of this shows what happens in tired people.

A proposed mechanism does not show that the effect happens in people.

The same trial had similar side-effect rates on extract and placebo (24% and 28% per the EMA report).

19 34 47

Stress-related tiredness and weak work capacity

Not enough evidence

A German trial of 144 people found that adding eleutherococcus root extract to stress training gave no extra benefit. Everyone in every group got better over time.

2 studiesRoot extract; single product.

Studies, doses and limits

What the trials found

Schaffler 2013 randomised 144 people with stress-related weakness to the root extract, a 2-day stress management course, or both. Almost every score improved over time with no difference between groups. Adding the extract to training gave no benefit that could be separated from chance. There was no placebo-only arm, so the improvement cannot be credited to any one treatment.

Results

No added benefit from the extract.

Effect sizes as reported

No meaningful group differences on almost all measures.

Why this rating

One trial without a placebo-only arm, and its authors found no extra benefit.

Form and dose studied

Root extract; single product.

Who was studied

Adults with chronic stress, tiredness and reduced work capacity.

Limits

No placebo-only arm; short (8 weeks).

Why researchers looked

Tested as an adaptogen: a plant said to help the body cope with stress.

Traditional use

Eleutherococcus root has been used in Soviet-era and later European medicine as a tonic for tiredness and weakness, and in traditional Chinese medicine as 'ci wu jia'. The EU recognises it as a traditional herbal medicine for symptoms of asthenia (tiredness and weakness) based on long use, not on proof from trials.

Proposed mechanism Preliminary mechanism

Lab and animal work suggests eleutherosides and other root compounds may influence stress-hormone signalling and inflammation pathways. The EMA report notes that an extract raised corticosterone in rats and bound several hormone receptors in rat tissue in vitro. None of this shows what happens in tired people.

A proposed mechanism does not show that the effect happens in people.

All treatments were well tolerated.

38 47

Burnout (in a four-ingredient product)

Not enough evidence

A French trial of a four-ingredient supplement that includes Eleutherococcus found more improvement than placebo in burnout scores. This cannot be credited to Eleutherococcus alone.

1 studiesBranded combination (TARGET 1).

Studies, doses and limits

What the trials found

Jacquet 2015 randomised 87 workers with burnout to a supplement (casozepine, taurine, Eleutherococcus senticosus and extramel) or placebo for 12 weeks. The product group improved on all five scores and more than placebo; placebo also improved. Values are not in the abstract.

Results

Greater improvement than placebo, but for a mixed product.

Effect sizes as reported

Not reported in the abstract.

Why this rating

A combination product: the result cannot be assigned to Eleutherococcus. Numbers were not read. Funding not stated.

Form and dose studied

Branded combination (TARGET 1).

Who was studied

Workers with burnout in client-facing jobs.

Limits

Cannot separate one ingredient from another.

Why researchers looked

Burnout is a common reason people try adaptogen products.

Traditional use

Not specific to eleuthero.

Proposed mechanism Pharmacological theory

Not tested for this product.

A proposed mechanism does not show that the effect happens in people.

No safety signal in the abstract.

21

Quality of life in older people

Not enough evidence

A tiny trial of 20 older people found a better social-functioning score after 4 weeks, which was gone by 8 weeks.

1 studiesDry extract.

Studies, doses and limits

What the trials found

Cicero 2004 gave 20 older people with high blood pressure who took digitalis either root dry extract or placebo for 8 weeks. Social functioning on the SF-36 was higher at 4 weeks (P = 0.02) but not at 8 weeks. No difference in blood pressure control or digoxin level. More people on the extract guessed they were on active treatment.

Results

Small, short-lived gain on one scale.

Effect sizes as reported

Social functioning higher at week 4 (P = 0.02), not at week 8.

Why this rating

Ten people per group, many scales tested, effect did not last.

Form and dose studied

Dry extract.

Who was studied

Older adults with high blood pressure on digitalis.

Limits

Very small; possible loss of blinding.

Why researchers looked

Fatigue and low energy are common in older age and a traditional reason to use tonics.

Traditional use

Eleutherococcus root has been used in Soviet-era and later European medicine as a tonic for tiredness and weakness, and in traditional Chinese medicine as 'ci wu jia'. The EU recognises it as a traditional herbal medicine for symptoms of asthenia (tiredness and weakness) based on long use, not on proof from trials.

Proposed mechanism Pharmacological theory

Lab and animal work suggests eleutherosides and other root compounds may influence stress-hormone signalling and inflammation pathways. The EMA report notes that an extract raised corticosterone in rats and bound several hormone receptors in rat tissue in vitro. None of this shows what happens in tired people.

A proposed mechanism does not show that the effect happens in people.

No adverse events and no change in digoxin level in this trial.

6

Attention and speed when tired (in a three-herb product)

Not enough evidence

One single-dose pilot found a three-herb mix improved attention in 40 stressed women within two hours. This cannot be credited to Eleutherococcus alone.

1 studiesADAPT-232 combination tablet.

Studies, doses and limits

What the trials found

Aslanyan 2010 compared one tablet of ADAPT-232 (Rhodiola, Schisandra and Eleutherococcus extracts) with placebo in 40 stressed women. The mix group scored higher for attention, speed and accuracy two hours later (P < 0.05).

Results

Better d2 attention scores for a three-herb mix after one dose.

Effect sizes as reported

P < 0.05 on the d2 test (values not in the abstract).

Why this rating

Single dose, 40 people, three herbs together, pilot.

Form and dose studied

ADAPT-232 combination tablet.

Who was studied

Healthy women aged 20 to 68 reporting long-term stress.

Limits

Cannot separate the herbs; effect after one dose may not carry to longer use.

Why researchers looked

Adaptogen mixes are tested for mental performance under stress.

Traditional use

Not specific to eleuthero.

Proposed mechanism Pharmacological theory

Not tested for this product.

A proposed mechanism does not show that the effect happens in people.

Minor events (sleepiness, cold extremities) in both groups.

2

Memory and thinking tests (leaf extract with another herb)

Not enough evidence

A Japanese trial of the plant's leaf extract combined with Drynaria rhizome found small gains in one memory test. It used leaf, not the usual root, so it says little about eleuthero root products.

1 studiesWater extracts of leaf plus Drynaria rhizome.

Studies, doses and limits

What the trials found

Tohda 2020 gave a combination of E. senticosus leaf and Drynaria rhizome water extracts to healthy adults for 12 weeks. The combination beat placebo on the figure-recall subscore (P = 0.045); other gains were within-group only.

Results

One subtest higher than placebo.

Effect sizes as reported

Figure recall P = 0.045; other results within-group.

Why this rating

Leaf and a second herb; sample size not in the abstract; many tests.

Form and dose studied

Water extracts of leaf plus Drynaria rhizome.

Who was studied

Healthy adults.

Limits

Different plant part, combination, many comparisons.

Why researchers looked

Mouse studies by the same group suggested the leaf extract improved memory.

Traditional use

Not part of the main traditional use of the root.

Proposed mechanism Animal research

Animal work reported by the authors, not read in detail.

A proposed mechanism does not show that the effect happens in people.

No adverse effects reported.

43

Mood: added to lithium in bipolar disorder (teenagers)

Not enough evidence

A Chinese trial of 76 teenagers on lithium found the herb performed about the same as fluoxetine, with fewer people switching to mania. There was no placebo group.

2 studiesRoot-derived herb, details not in the part read.

Studies, doses and limits

What the trials found

Weng 2007 randomised 76 adolescents with bipolar disorder (all taking lithium) to added Acanthopanax senticosus or added fluoxetine for 6 weeks. Response was 67.6% versus 71.8% and remission 51.4% versus 48.7%. Three on fluoxetine switched to mania; none on the herb.

Results

Similar to fluoxetine, no placebo comparison.

Effect sizes as reported

Response 67.6% vs 71.8%; remission 51.4% vs 48.7%.

Why this rating

One trial, no placebo arm, young patients, single country.

Form and dose studied

Root-derived herb, details not in the part read.

Who was studied

Adolescents aged 12 to 17 with bipolar disorder on lithium.

Limits

No placebo; cannot show the herb works.

Why researchers looked

Some Chinese studies have examined mood effects of the herb.

Traditional use

Traditional Chinese use includes calming and memory.

Proposed mechanism Animal research

Lab studies suggest effects on nerve signalling and inflammation; a review of mostly animal work supports this.

A proposed mechanism does not show that the effect happens in people.

Bipolar disorder needs specialist care. Do not add any herb without the treating doctor knowing. Side effects in the trial were nausea, rash and diarrhoea.

44 29

Cancer-related fatigue

Not enough evidence

A small Japanese feasibility study found only half of 15 patients completed 28 days; milder cases may have improved. It is too small to say anything about benefit.

1 studiesFood drink containing Acanthopanax senticosus.

Studies, doses and limits

What the trials found

Kawano 2024: 15 patients drank an Acanthopanax senticosus drink for 28 days; 7 finished. Four with milder fatigue had lower scores. No adverse events attributed to the drink.

Results

No reliable result.

Effect sizes as reported

7 of 15 completed.

Why this rating

No control group; feasibility only.

Form and dose studied

Food drink containing Acanthopanax senticosus.

Who was studied

Adults with cancer-related fatigue.

Limits

No control group, high dropout.

Why researchers looked

Cancer-related fatigue has few treatments, so adaptogen foods are being explored.

Traditional use

Not a traditional indication.

Proposed mechanism Pharmacological theory

None established.

A proposed mechanism does not show that the effect happens in people.

If you are having cancer treatment, ask your oncology team first.

24

Stress physiology: heart rate variability in older adults

Not enough evidence

A small Japanese trial of a supplement found better heart-rate-variability readings after 4 weeks. It is a lab measure and the supplement maker was involved.

1 studiesASH supplement (preparation not detailed in abstract).

Studies, doses and limits

What the trials found

Sato 2024 randomised 28 older adults to Acanthopanax senticosus Harms supplement or placebo for 4 weeks; CVRR, HF, LF/HF, systolic blood pressure and heart rate improved significantly in the supplement group only (numbers not in the abstract).

Results

Better heart-rate-variability readings.

Effect sizes as reported

Significant group-time effects for CVRR, HF and delta LF/HF.

Why this rating

28 people, a lab marker not a symptom, industry-linked authors.

Form and dose studied

ASH supplement (preparation not detailed in abstract).

Who was studied

Healthy older adults.

Limits

Industry-linked; surrogate outcome.

Why researchers looked

Heart rate variability reflects the stress-related balance of the nervous system.

Traditional use

Anti-stress use in Japanese and Chinese practice.

Proposed mechanism Pharmacological theory

Not established.

A proposed mechanism does not show that the effect happens in people.

Blood pressure fell in the supplement group in this trial.

37

Stress hormones in athletes

Not enough evidence

In endurance athletes, eleutherococcus extract made a stress-hormone ratio go the wrong way for a benefit: the testosterone-to-cortisol ratio fell and cortisol tended to rise.

2 studies33% ethanol root extract.

Studies, doses and limits

What the trials found

Gaffney 2001: in athletes taking a 33% ethanol extract for 6 weeks, TCR fell 28.7% (P = 0.03), cortisol tended to rise 31% (P = 0.07, not significant), testosterone dropped 7% (not significant). No immune counts changed.

Results

Stress-hormone index moved against the hoped-for direction.

Effect sizes as reported

TCR -28.7% (P = 0.03).

Why this rating

One study; the cortisol change was not significant; group sizes not in the abstract.

Form and dose studied

33% ethanol root extract.

Who was studied

Competitive endurance athletes.

Limits

Small; athletes in heavy training.

Why researchers looked

Adaptogens are said to normalise stress hormones.

Traditional use

Soviet-era athletes used the extract as a tonic.

Proposed mechanism Preliminary mechanism

A theory paper proposes a two-way effect through COMT; untested.

A proposed mechanism does not show that the effect happens in people.

The result suggests the herb does not simply 'lower stress hormones'.

14 15

Exercise and endurance

Mixed findings

Two small US trials in trained athletes found no boost in endurance or race performance. A small Taiwanese trial of 9 men found a 12% higher oxygen capacity and 23% longer time to exhaustion. The results conflict.

4 studiesExtracts of different strengths and durations.

Studies, doses and limits

What the trials found

Dowling 1996 (20 trained runners, 6 weeks) and Eschbach 2000 (9 trained cyclists, 7 days, crossover) found no benefit on endurance or time trial. Kuo 2010 (9 recreationally trained men, 8 weeks, crossover) found VO2 peak up 12% and endurance time up 23%. The EMA assessment says the Kuo group is too small to prove efficacy.

Results

Two null trials and one small positive trial.

Effect sizes as reported

Kuo: VO2 peak +12%, endurance time +23% (both P < 0.05). Dowling and Eschbach: no significant difference.

Why this rating

Three small trials pointing in different directions; participants and doses differ.

Form and dose studied

Extracts of different strengths and durations.

Who was studied

Trained runners and cyclists; recreationally trained young men.

Limits

All trials have 9 to 20 people; the positive one is a 9-person crossover.

Why researchers looked

Sports use was one of the first modern uses of the root.

Traditional use

Soviet researchers in the 1960s promoted the root as a tonic for athletes and workers under strain, and it was approved in 1962 in the former Soviet Union as a 'stimulant' (EMA assessment report). Traditional Chinese medicine calls it 'ci wu jia'.

Proposed mechanism Preliminary mechanism

Lab work suggests compounds may change how the body uses fats and sugars, but no mechanism has been shown in people.

A proposed mechanism does not show that the effect happens in people.

Taken close to bedtime it may disturb sleep (EMA report). Trial participants reported no problems.

11 12 26 47

Coughs and colds (in three-herb products)

Very low certainty

Trials of Kan Jang, a mix of Adhatoda, Echinacea and Eleutherococcus, found faster relief of cough. It cannot be credited to Eleutherococcus alone.

2 studiesFixed three-herb combination (Kan Jang).

Studies, doses and limits

What the trials found

Narimanian 2005 found KanJang gave a general symptom benefit and a 2-day shorter recovery than bromhexine. Barth 2015 (177 adults, 5 days) found Kan Jang and bromhexine both eased cough more than placebo, with faster improvement on days 3 and 4 with Kan Jang.

Results

Cough eased faster with the mixture.

Effect sizes as reported

Recovery 2 days shorter (Narimanian); better cough relief than placebo (Barth).

Why this rating

Combination product; numbers not in abstracts; funding unknown.

Form and dose studied

Fixed three-herb combination (Kan Jang).

Who was studied

Adults with colds and mild respiratory infections.

Limits

Cannot separate the herbs from each other.

Why researchers looked

Adaptogen mixes are tested for respiratory infections.

Traditional use

Not a main traditional use of eleuthero.

Proposed mechanism Laboratory research

Immune effects in lab studies (see the immune review).

A proposed mechanism does not show that the effect happens in people.

No major adverse effects in the trials. Swedish spontaneous reports for a similar Echinacea, Eleutherococcus and Adhatoda product included allergic reactions (see safety file).

31 5

Recovery from pneumonia (three-herb product plus antibiotics)

Not enough evidence

One pilot of 60 people found a three-herb mix, taken with antibiotics, shortened antibiotic treatment by 2 days.

1 studiesADAPT-232 combination.

Studies, doses and limits

What the trials found

Narimanian 2005 (Chisan, ADAPT-232) added to standard treatment shortened antibiotic need by 2 days and raised quality-of-life scores.

Results

Shorter antibiotic treatment.

Effect sizes as reported

2 days shorter.

Why this rating

Pilot, three herbs, 60 patients.

Form and dose studied

ADAPT-232 combination.

Who was studied

Adults with acute non-specific pneumonia.

Limits

Not enough to change how pneumonia is treated.

Why researchers looked

Tested as an add-on to antibiotics.

Traditional use

Not traditional.

Proposed mechanism Pharmacological theory

Not established.

A proposed mechanism does not show that the effect happens in people.

Pneumonia needs a doctor and proven medicines.

32

Immune cell numbers

Evidence against

A study of athletes found no change in immune cell counts. Lab reviews suggest effects on immune signalling, but human proof is lacking.

3 studiesEthanol extract; Taiga Wurzel preparation.

Studies, doses and limits

What the trials found

Gaffney 2001: no change in T-cell, NK or B-cell counts after 6 weeks. Szolomicki 2000 reported effects on 'cellular defence' for a Taiga Wurzel preparation, without a placebo group and without numbers in the abstract.

Results

No change in a controlled trial.

Effect sizes as reported

No significant change.

Why this rating

A controlled trial found no change; the positive-looking study had no placebo.

Form and dose studied

Ethanol extract; Taiga Wurzel preparation.

Who was studied

Athletes; healthy volunteers.

Limits

Counts of cells are not the same as fewer infections.

Why researchers looked

Called an immunostimulant in older literature.

Traditional use

Historical 'immune tonic' use.

Proposed mechanism Laboratory research

Lab studies show isofraxidin, syringin and eleutheroside E can change immune signals; the whole water extract looked strongest.

A proposed mechanism does not show that the effect happens in people.

None specific.

14 41 28

Fever attacks in children with Familial Mediterranean Fever

Not enough evidence

A pilot in 24 children found a four-herb product reduced attack severity. It also contained licorice and cannot be credited to Eleutherococcus.

1 studiesImmunoGuard (four-herb mix).

Studies, doses and limits

What the trials found

Amaryan 2003: 14 children on the mix and 10 on placebo for 1 month; attack duration, frequency and severity improved more with the mix.

Results

Better attack scores.

Effect sizes as reported

All three features significantly improved.

Why this rating

Pilot, 24 children, four herbs.

Form and dose studied

ImmunoGuard (four-herb mix).

Who was studied

Children aged 3 to 15 with FMF.

Limits

Tiny pilot; licorice can raise blood pressure.

Why researchers looked

Pilot work on an inherited fever disorder.

Traditional use

Not traditional.

Proposed mechanism Pharmacological theory

Not established.

A proposed mechanism does not show that the effect happens in people.

This should only be tried under the care of the child's specialist.

1

Blood sugar

Not enough evidence

In 12 healthy people, Siberian ginseng raised blood sugar after a sugar drink. Hints of lower blood sugar come from animal work and one exercise trial. Anyone on diabetes medicines should watch this closely.

2 studiesPowder in Sievenpiper; extract in Kuo.

Studies, doses and limits

What the trials found

Sievenpiper 2004: a single dose of Siberian ginseng raised blood glucose compared with placebo after a sugar drink (P < 0.05) in 12 healthy adults. Kuo 2010: blood glucose was lower at 30 minutes of hard cycling on the extract. No trial in people with diabetes was found.

Results

Mixed signals; none in people with diabetes.

Effect sizes as reported

Higher glucose after a sugar drink (P < 0.05, values not in the abstract); lower glucose at 30 min cycling (P < 0.05).

Why this rating

Two small studies pointing in different directions, neither in diabetes.

Form and dose studied

Powder in Sievenpiper; extract in Kuo.

Who was studied

Healthy adults.

Limits

Single-dose study; acute effect only.

Why researchers looked

Reviews describe 'antidiabetic' effects, mostly from animal studies.

Traditional use

Some sources describe use for blood sugar.

Proposed mechanism Animal research

Animal and lab studies report glucose-lowering by individual compounds; not shown in people.

A proposed mechanism does not show that the effect happens in people.

LactMed warns eleuthero may raise blood sugar; the EMA report says to consider drugs that lower blood sugar. Anyone with diabetes should talk to their doctor.

39 26

Blood pressure

Mixed findings

Evidence is mixed and thin. Two trials showed no blood-pressure change, a fruit-extract trial lowered it, an old Russian child study raised low blood pressure, and one review lists Siberian ginseng among supplements that raise it.

5 studiesRoot extract and fruit extract.

Studies, doses and limits

What the trials found

Cicero 2004 (older adults on digitalis) found no difference in blood pressure control. In Hartz 2004 blood pressure did not differ between groups (EMA report). Oh 2020 used the FRUIT and found a systolic pressure fall (-7.7 vs +0.1 mmHg) at the lower dose. Kaloeva 1986 (Russian abstract) reported raised pressure in children with low pressure. Rasmussen 2012 lists Siberian ginseng among supplements consistently associated with raised blood pressure.

Results

Mixed: no change, fall (fruit), rise (children, review).

Effect sizes as reported

Oh 2020: -7.7 vs +0.1 mmHg systolic (P = 0.044).

Why this rating

Small trials, different plant parts, one review claim not traceable from its abstract.

Form and dose studied

Root extract and fruit extract.

Who was studied

Older adults; healthy adults with borderline pressure; children with low pressure.

Limits

The fruit is not the root. Old Russian data are weak.

Why researchers looked

Old sources both used it for low blood pressure and warned against it in high blood pressure.

Traditional use

Older guides listed high blood pressure as a reason to avoid it; the EMA removed that warning in its 2014 review for lack of evidence.

Proposed mechanism Pharmacological theory

Not established.

A proposed mechanism does not show that the effect happens in people.

People with heart disease or high blood pressure should check with their doctor. EMA lists tachycardia as a possible effect.

6 33 23 35 47

Cholesterol and blood fats

Not enough evidence

One small study with no placebo group saw changes in cholesterol and triglycerides after 30 days, but the abstract does not say which direction.

2 studiesTaiga Wurzel (root preparation).

Studies, doses and limits

What the trials found

Szolomicki 2000: in 35 people taking Taiga Wurzel for 30 days, total cholesterol, LDL, triglycerides and glucose changed; no change in 15 people on Echinacea. Direction and size are not in the abstract. The EMA report says old trials claimed lower cholesterol but lacked proper methods.

Results

Changes noted, direction not stated.

Effect sizes as reported

No numbers in abstract.

Why this rating

No placebo, no numbers in the abstract.

Form and dose studied

Taiga Wurzel (root preparation).

Who was studied

Healthy volunteers.

Limits

Cannot say whether cholesterol rose or fell.

Why researchers looked

Old Soviet reports mention cholesterol falls.

Traditional use

Noted in the EMA report as a claim from old trials.

Proposed mechanism Pharmacological theory

Not established.

A proposed mechanism does not show that the effect happens in people.

None specific.

41 47

Bone health after menopause

Very low certainty

In 81 postmenopausal Korean women a bone-building marker rose after 6 months, but bone density did not change.

1 studiesExtract of A. senticosus.

Studies, doses and limits

What the trials found

Hwang 2009: 3 g a day of extract plus calcium vs calcium alone for 6 months. Osteocalcin higher (P = 0.041); BMD unchanged; adverse events similar.

Results

Marker up, bone density no different.

Effect sizes as reported

Osteocalcin P = 0.041; BMD no change.

Why this rating

One trial with no placebo; the clinical outcome (BMD) did not change.

Form and dose studied

Extract of A. senticosus.

Who was studied

Postmenopausal women with osteopenia or osteoporosis.

Limits

No placebo; no fracture data.

Why researchers looked

Animal work has examined bone effects; none was read here.

Traditional use

Chinese tradition says it strengthens bones.

Proposed mechanism Animal research

Animal work only (not read here).

A proposed mechanism does not show that the effect happens in people.

No difference in adverse events. Hormone-sensitive conditions are discussed in the safety file.

20

Hangover symptoms

Not enough evidence

A crossover trial of a polysaccharide-rich extract found less severe hangover symptoms the next morning, though it did not lower blood alcohol.

1 studiesPolysaccharide-rich extract.

Studies, doses and limits

What the trials found

Bang 2015: blood alcohol was the same, but hangover score and several items improved, and rises in glucose disturbance and CRP were reduced (numbers not in the abstract).

Results

Hangover score improved.

Effect sizes as reported

Significant improvement in total hangover score (values not given).

Why this rating

Single small crossover; numbers missing.

Form and dose studied

Polysaccharide-rich extract.

Who was studied

Healthy adults.

Limits

Abstract has no group size.

Why researchers looked

Tested because of the plant's liver-protecting reputation in East Asia.

Traditional use

Traditional East Asian use for the liver.

Proposed mechanism Animal research

Animal work on alcohol and the liver.

A proposed mechanism does not show that the effect happens in people.

Alcohol is harmful regardless; the herb is not a way to drink safely.

4

Leg swelling

Not enough evidence

In a 50-woman crossover study, a single serving of Siberian ginseng powder reduced lower-leg swelling at 2 and 4 hours. The authors work for a cosmetics company.

1 studiesSiberian ginseng powder.

Studies, doses and limits

What the trials found

Fukada 2016: swelling lower at 2 and 4 hours than control.

Results

Less leg swelling for a few hours.

Effect sizes as reported

Significant reduction at 2 and 4 hours (numbers not in the abstract).

Why this rating

Short-term, one study, industry-linked.

Form and dose studied

Siberian ginseng powder.

Who was studied

Healthy women.

Limits

Short-term; industry authors.

Why researchers looked

Looked at because lab tests suggest effects on lymph vessels.

Traditional use

Not traditional.

Proposed mechanism Laboratory research

Lab cell tests: eleutheroside E and the extract activated a vessel receptor (Tie2).

A proposed mechanism does not show that the effect happens in people.

None specific.

13

Female sexual function (in a combined supplement)

Not enough evidence

A trial of a vitamin E plus two-ginseng supplement found better desire and satisfaction scores but no difference in the total score.

1 studiesVitamin E plus Korean ginseng plus Siberian ginseng.

Studies, doses and limits

What the trials found

Ghamari 2020: 69 women enrolled, 31 per group finished; the supplement beat placebo for desire and satisfaction domains only.

Results

Two sub-scores better, total score not.

Effect sizes as reported

Total FSFI no difference.

Why this rating

Mixed product with a small amount of Siberian ginseng.

Form and dose studied

Vitamin E plus Korean ginseng plus Siberian ginseng.

Who was studied

Women with sexual dysfunction.

Limits

Dropouts; cannot credit Siberian ginseng.

Why researchers looked

Tested as a ginseng-type supplement.

Traditional use

Not traditional for eleuthero.

Proposed mechanism Pharmacological theory

Not established.

A proposed mechanism does not show that the effect happens in people.

None specific.

17

Connections to the rest of health

How Eleuthero connects to the rest of our health knowledge graph. Every link says what kind of connection it is. A safety link (for example to the liver) is a warning, not a benefit. A study that merely mentions a topic never creates a benefit link.

Explore every connection: goals, body systems, organs, symptoms, genes

A. Wellness goals

Connected toKind of connectionEvidence statusContextStudies
Reduce Fatigue Potential benefit Very low certainty Long-lasting unexplained fatigue: In one US trial of 96 people with fatigue for six months or more, Siberian ginseng did not beat placebo overall. A hint of benefit in people with less severe fatigue was an exploratory finding. Quality of life in older people: A tiny trial of 20 older people found a better social-functioning score after 4 weeks, which was gone by 8 weeks. 19 34 47 6 24
Energy Boost Potential benefit Very low certainty Long-lasting unexplained fatigue: In one US trial of 96 people with fatigue for six months or more, Siberian ginseng did not beat placebo overall. A hint of benefit in people with less severe fatigue was an exploratory finding. 19 34 47
Stress Reduction Biological association Not enough evidence Stress-related tiredness and weak work capacity: A German trial of 144 people found that adding eleutherococcus root extract to stress training gave no extra benefit. Everyone in every group got better over time. Stress hormones in athletes: In endurance athletes, eleutherococcus extract made a stress-hormone ratio go the wrong way for a benefit: the testosterone-to-cortisol ratio fell and cortisol tended to rise. 38 47 14 15
Reduce Fatigue Biological association Not enough evidence Stress-related tiredness and weak work capacity: A German trial of 144 people found that adding eleutherococcus root extract to stress training gave no extra benefit. Everyone in every group got better over time. 38 47
Resilience Support Biological association Not enough evidence Stress-related tiredness and weak work capacity: A German trial of 144 people found that adding eleutherococcus root extract to stress training gave no extra benefit. Everyone in every group got better over time. 38 47
Burnout Recovery Potential benefit Not enough evidence Burnout (in a four-ingredient product): A French trial of a four-ingredient supplement that includes Eleutherococcus found more improvement than placebo in burnout scores. This cannot be credited to Eleutherococcus alone. 21
Stress Reduction Potential benefit Not enough evidence Burnout (in a four-ingredient product): A French trial of a four-ingredient supplement that includes Eleutherococcus found more improvement than placebo in burnout scores. This cannot be credited to Eleutherococcus alone. 21
Healthy Aging Potential benefit Not enough evidence Quality of life in older people: A tiny trial of 20 older people found a better social-functioning score after 4 weeks, which was gone by 8 weeks. Stress physiology: heart rate variability in older adults: A small Japanese trial of a supplement found better heart-rate-variability readings after 4 weeks. It is a lab measure and the supplement maker was involved. 6 37 20
Better Focus Potential benefit Not enough evidence Attention and speed when tired (in a three-herb product): One single-dose pilot found a three-herb mix improved attention in 40 stressed women within two hours. This cannot be credited to Eleutherococcus alone. 2
Mental Clarity Potential benefit Not enough evidence Attention and speed when tired (in a three-herb product): One single-dose pilot found a three-herb mix improved attention in 40 stressed women within two hours. This cannot be credited to Eleutherococcus alone. 2
Cognitive Performance Potential benefit Not enough evidence Attention and speed when tired (in a three-herb product): One single-dose pilot found a three-herb mix improved attention in 40 stressed women within two hours. This cannot be credited to Eleutherococcus alone. Memory and thinking tests (leaf extract with another herb): A Japanese trial of the plant's leaf extract combined with Drynaria rhizome found small gains in one memory test. It used leaf, not the usual root, so it says little about eleuthero root products. 2 43
Memory Support Potential benefit Not enough evidence Memory and thinking tests (leaf extract with another herb): A Japanese trial of the plant's leaf extract combined with Drynaria rhizome found small gains in one memory test. It used leaf, not the usual root, so it says little about eleuthero root products. 43
Mood Balance Potential benefit Not enough evidence Mood: added to lithium in bipolar disorder (teenagers): A Chinese trial of 76 teenagers on lithium found the herb performed about the same as fluoxetine, with fewer people switching to mania. There was no placebo group. 44 29
Resilience Support Potential benefit Not enough evidence Stress physiology: heart rate variability in older adults: A small Japanese trial of a supplement found better heart-rate-variability readings after 4 weeks. It is a lab measure and the supplement maker was involved. 37
Adrenal Support Biological association Not enough evidence Stress hormones in athletes: In endurance athletes, eleutherococcus extract made a stress-hormone ratio go the wrong way for a benefit: the testosterone-to-cortisol ratio fell and cortisol tended to rise. 14 15
Endurance Support Potential benefit Mixed findings Exercise and endurance: Two small US trials in trained athletes found no boost in endurance or race performance. A small Taiwanese trial of 9 men found a 12% higher oxygen capacity and 23% longer time to exhaustion. The results conflict. 11 12 26 47
Physical Stamina Potential benefit Mixed findings Exercise and endurance: Two small US trials in trained athletes found no boost in endurance or race performance. A small Taiwanese trial of 9 men found a 12% higher oxygen capacity and 23% longer time to exhaustion. The results conflict. 11 12 26 47
Peak Performance Potential benefit Mixed findings Exercise and endurance: Two small US trials in trained athletes found no boost in endurance or race performance. A small Taiwanese trial of 9 men found a 12% higher oxygen capacity and 23% longer time to exhaustion. The results conflict. 11 12 26 47
Immune Support Potential benefit Very low certainty Coughs and colds (in three-herb products): Trials of Kan Jang, a mix of Adhatoda, Echinacea and Eleutherococcus, found faster relief of cough. It cannot be credited to Eleutherococcus alone. Recovery from pneumonia (three-herb product plus antibiotics): One pilot of 60 people found a three-herb mix, taken with antibiotics, shortened antibiotic treatment by 2 days. 31 5 32 1
Immune Support Biological association Evidence against Immune cell numbers: A study of athletes found no change in immune cell counts. Lab reviews suggest effects on immune signalling, but human proof is lacking. 14 41 28
Inflammation Balance Potential benefit Not enough evidence Fever attacks in children with Familial Mediterranean Fever: A pilot in 24 children found a four-herb product reduced attack severity. It also contained licorice and cannot be credited to Eleutherococcus. 1
Blood Sugar Balance Biological association Not enough evidence Blood sugar: In 12 healthy people, Siberian ginseng raised blood sugar after a sugar drink. Hints of lower blood sugar come from animal work and one exercise trial. Anyone on diabetes medicines should watch this closely. 39 26
Metabolic Health Biological association Not enough evidence Blood sugar: In 12 healthy people, Siberian ginseng raised blood sugar after a sugar drink. Hints of lower blood sugar come from animal work and one exercise trial. Anyone on diabetes medicines should watch this closely. 39 26
Blood Pressure Support Biological association Mixed findings Blood pressure: Evidence is mixed and thin. Two trials showed no blood-pressure change, a fruit-extract trial lowered it, an old Russian child study raised low blood pressure, and one review lists Siberian ginseng among supplements that raise it. 6 33 23 35 47
Heart Health Biological association Mixed findings Blood pressure: Evidence is mixed and thin. Two trials showed no blood-pressure change, a fruit-extract trial lowered it, an old Russian child study raised low blood pressure, and one review lists Siberian ginseng among supplements that raise it. 6 33 23 35 47
Cholesterol Balance Potential benefit Not enough evidence Cholesterol and blood fats: One small study with no placebo group saw changes in cholesterol and triglycerides after 30 days, but the abstract does not say which direction. 41 47
Menopause Support Potential benefit Very low certainty Bone health after menopause: In 81 postmenopausal Korean women a bone-building marker rose after 6 months, but bone density did not change. 20
Digestive Support Potential benefit Not enough evidence Hangover symptoms: A crossover trial of a polysaccharide-rich extract found less severe hangover symptoms the next morning, though it did not lower blood alcohol. 4
Healthy Skin Potential benefit Not enough evidence Leg swelling: In a 50-woman crossover study, a single serving of Siberian ginseng powder reduced lower-leg swelling at 2 and 4 hours. The authors work for a cosmetics company. 13
Womens Wellness Potential benefit Not enough evidence Leg swelling: In a 50-woman crossover study, a single serving of Siberian ginseng powder reduced lower-leg swelling at 2 and 4 hours. The authors work for a cosmetics company. Female sexual function (in a combined supplement): A trial of a vitamin E plus two-ginseng supplement found better desire and satisfaction scores but no difference in the total score. 13 17
Libido Support Potential benefit Not enough evidence Female sexual function (in a combined supplement): A trial of a vitamin E plus two-ginseng supplement found better desire and satisfaction scores but no difference in the total score. 17

B. Body systems

Connected toKind of connectionEvidence statusContextStudies
Cardiovascular system Adverse effect or risk Low certainty Tachycardia and palpitations listed; blood pressure effects disputed.
Preparation or compound: Root extract
48 35
Nervous System Biological association Very low certainty Studied for: Long-lasting unexplained fatigue Studied for: Stress-related tiredness and weak work capacity 19 34 47 38 6 2 43 44 29 24 37
Stress Mood Biological association Very low certainty Studied for: Long-lasting unexplained fatigue Studied for: Stress-related tiredness and weak work capacity 19 34 47 38 21
Cardiovascular System Biological association Not enough evidence Studied for: Stress physiology: heart rate variability in older adults Studied for: Exercise and endurance 37 11 12 26 47 6 33 23 35 41 13
Endocrine System Biological association Not enough evidence Studied for: Stress hormones in athletes Studied for: Blood sugar 14 15 39 26
Musculoskeletal System Biological association Mixed findings Studied for: Exercise and endurance Studied for: Bone health after menopause 11 12 26 47 20
Respiratory System Biological association Very low certainty Studied for: Coughs and colds (in three-herb products) Studied for: Recovery from pneumonia (three-herb product plus antibiotics) 31 5 32
Immune System Biological association Very low certainty Studied for: Coughs and colds (in three-herb products) Studied for: Recovery from pneumonia (three-herb product plus antibiotics) 31 5 32 14 41 28 1
Metabolism Weight Biological association Not enough evidence Studied for: Blood sugar Studied for: Hangover symptoms 39 26 4
Reproductive System Biological association Not enough evidence Studied for: Female sexual function (in a combined supplement) 17

D. Symptoms

Connected toKind of connectionEvidence statusContextStudies
Fatigue Traditional use Very low certainty Traditional use accepted by the EU; one trial found no overall difference from placebo.
Preparation or compound: Root extract
19 48
Stress and burnout Potential benefit Not enough evidence No added benefit over stress training in one trial; burnout result is from a four-ingredient product.
Preparation or compound: Root extract; combination product
38 21
Exercise performance Potential benefit Mixed findings Two null trials and one small positive trial.
Preparation or compound: Extract
11 12 26

E. Health conditions

Connected toKind of connectionEvidence statusContextStudies
Pregnancy Contraindication Not enough evidence Not recommended; safety not established.
Preparation or compound: Root preparations
48
Breastfeeding Contraindication Not enough evidence No data in nursing mothers; most sources advise against use.
Preparation or compound: Root preparations
27
Diabetes Drug or supplement interaction Very low certainty May raise or lower blood sugar; no trial in diabetes. Blood sugar rose in healthy people after a sugar drink; no trial in diabetes.
Preparation or compound: Root extract or powder
39 27
Bleeding Adverse effect or risk Very low certainty Case reports of bleeding with antidepressants; LactMed says it may increase bleeding.
Preparation or compound: Root extract with antidepressants or alone
40 27
Hormone-sensitive conditions Contraindication Not enough evidence Receptor binding in rat tissue and breast tenderness in one trial; no human data in cancers.
Preparation or compound: Root extract
47 19
Pregnancy and breastfeeding Contraindication Not enough evidence Safety not established; use not recommended by the EU.
Preparation or compound: Root
48 27
Bleeding and blood thinners Drug or supplement interaction Very low certainty Case reports with antidepressants; LactMed says it may increase bleeding.
Preparation or compound: Extract
40 27

I. Biomarkers

Connected toKind of connectionEvidence statusContextStudies
Cortisol (stress hormone) Biological association Very low certainty Measured in trials: mixed. A lab change is not the same as a health benefit. 14 38
Testosterone-to-cortisol ratio Biological association Very low certainty Measured in trials: lowered. A lab change is not the same as a health benefit. 14
Heart rate variability (CVRR, HF, LF/HF) Biological association Not enough evidence Measured in trials: raised. A lab change is not the same as a health benefit. 37
Antioxidant-to-oxidant ratio (BAP/d-ROMs) Biological association Not enough evidence Measured in trials: no-change. A lab change is not the same as a health benefit. 24
Oxygen use at peak effort (VO2 peak) Biological association Very low certainty Measured in trials: raised. A lab change is not the same as a health benefit. 26 11 12
Time to exhaustion Biological association Mixed findings Measured in trials: mixed. A lab change is not the same as a health benefit. 26 11 12
Blood glucose Biological association Not enough evidence Measured in trials: mixed. A lab change is not the same as a health benefit. 39 26
Systolic blood pressure Biological association Mixed findings Measured in trials: mixed. A lab change is not the same as a health benefit. 33 6
Osteocalcin (bone-turnover marker) Biological association Very low certainty Measured in trials: raised. A lab change is not the same as a health benefit. 20
Bone mineral density (DXA scan) Biological association Low certainty Measured in trials: no-change. A lab change is not the same as a health benefit. 20
C-reactive protein (CRP) Biological association Not enough evidence Measured in trials: lowered. A lab change is not the same as a health benefit. 4
Immune cell counts (T-cells, NK cells, B-cells) Biological association Low certainty Measured in trials: no-change. A lab change is not the same as a health benefit. 14
Total cholesterol, LDL and triglycerides Biological association Not enough evidence Measured in trials: mixed. A lab change is not the same as a health benefit. 41

J. Genes, receptors and enzymes

Connected toKind of connectionEvidence statusContextStudies
BDNF (brain-derived neurotrophic factor) Preliminary mechanism Animal Increased in preclinical studies, per the 2025 review 34
TEK (Tie2 receptor) Preliminary mechanism In vitro Phosphorylated by Siberian ginseng and eleutheroside E in lymphatic cells 13
NOS3 (endothelial nitric oxide synthase, eNOS) Preliminary mechanism In vitro Phosphorylated in lymphatic cells; the phospho-eNOS to eNOS ratio was also higher in healthy adults taking a low dose of an A. senticosus FRUIT extract (different plant part; trial abstract) 13 33
ABCB1 (P-glycoprotein) Preliminary mechanism In vitro Suppressed by extract in Caco-2 gut cells 42
CYP2C9 and CYP2E1 Preliminary mechanism In vitro Weakly inhibited by eleutherosides in rat microsomes 18
COMT Preliminary mechanism Preliminary mechanism Proposed (untested) target in a theory paper 15
Glucocorticoid, mineralocorticoid and oestrogen receptors Preliminary mechanism Animal Extract bound these in rat tissue in vitro (EMA report) 47

K. Biological pathways

Connected toKind of connectionEvidence statusContextStudies
NF-kB / MAPK / Akt signalling Preliminary mechanism In vitro Inhibited by root extract in preclinical studies, per the 2025 review 34

L. Active compounds

Connected toKind of connectionEvidence statusContextStudies
Eleutheroside B (syringin) Biological association In vitro A marker compound. Patyra 2025 says syringin helps tell E. senticosus from other Araliaceae plants. Lab work links it to adaptogenic action; not shown in people.
Preparation or compound: root
34 47 53
Eleutheroside E (syringaresinol diglucoside) Biological association In vitro A marker compound. Activated a vessel receptor (Tie2) in lymphatic cells in the lab; reviewed as important in the adaptogenic response.
Preparation or compound: root
34 13 47 53
Isofraxidin (with eleutheroside B1) Biological association In vitro Modulated immune function in lab studies.
Preparation or compound: root
28 47 53
Chlorogenic acid and caffeic acid derivatives Biological association In vitro Caffeoylquinic acids are among the main constituents according to Patyra 2025.
Preparation or compound: root
34 47 53
Sesamin (eleutheroside B4) Biological association In vitro No specific activity read.
Preparation or compound: root
47 53
Beta-hederin (eleutheroside K) Biological association In vitro A saponin listed by the EMA report. No activity read.
Preparation or compound: root
47 53
Daucosterol (eleutheroside A, sitogluside) Biological association In vitro Listed by the EMA report. No activity read.
Preparation or compound: root
47 53
Coniferaldehyde and its glucoside Biological association In vitro Listed by the EMA report. No activity read.
Preparation or compound: root
47 53
Polysaccharides (eleutherans, heteroglycans) Biological association In vitro Polysaccharide-rich extracts were used in a hangover trial; water extract was the most potent for immune signals in a review.
Preparation or compound: root
47 28

Each connection is stored with the ingredient, the connected record, the kind of connection, the evidence status, the supporting studies, the preparation or compound involved, and a review date (last reviewed October 25, 2026).

Evidence at a glance: what changed in 13 lab markers

Tap a number to show only those markers. Counts are markers, not people.

The evidence

The research centre for Eleuthero. Every record here was checked against PubMed or the publisher's page; we never list a study we have not verified.

Evidence by outcome

Long-lasting unexplained fatigue 3 studies · 96 people in trials Very low certainty Stress-related tiredness and weak work capacity 2 studies · 144 people in trials Not enough evidence Burnout (in a four-ingredient product) 1 study · 87 people in trials Not enough evidence Quality of life in older people 1 study · 20 people in trials Not enough evidence Attention and speed when tired (in a three-herb product) 1 study · 40 people in trials Not enough evidence Memory and thinking tests (leaf extract with another herb) 1 study Not enough evidence Mood: added to lithium in bipolar disorder (teenagers) 2 studies · 76 people in trials Not enough evidence Cancer-related fatigue 1 study Not enough evidence Stress physiology: heart rate variability in older adults 1 study · 28 people in trials Not enough evidence Stress hormones in athletes 2 studies Not enough evidence Exercise and endurance 4 studies · 38 people in trials Mixed findings Coughs and colds (in three-herb products) 2 studies · 177 people in trials Very low certainty Recovery from pneumonia (three-herb product plus antibiotics) 1 study · 60 people in trials Not enough evidence Immune cell numbers 3 studies Evidence against Fever attacks in children with Familial Mediterranean Fever 1 study · 24 people in trials Not enough evidence Blood sugar 2 studies · 21 people in trials Not enough evidence Blood pressure 5 studies · 96 people in trials Mixed findings Cholesterol and blood fats 2 studies Not enough evidence Bone health after menopause 1 study · 81 people in trials Very low certainty Hangover symptoms 1 study Not enough evidence Leg swelling 1 study · 50 people in trials Not enough evidence Female sexual function (in a combined supplement) 1 study · 69 people in trials Not enough evidence

Bars show how many studies we found for each outcome, not how well it works. People are added up across trials only (reviews are not added, to avoid double counting).

How we rate evidence

High certainty

Several well-run trials or reviews agree; further research is unlikely to change the picture much.

Moderate certainty

Good trials point the same way, but some doubt remains.

Low certainty

Small, short or inconsistent trials. The finding could change with better research.

Very low certainty

Very little or very weak human data. Treat as a possibility only.

Mixed findings

Trials or reviews disagree with each other.

Not enough evidence

Not enough human research to say either way.

Evidence against

Good research found no benefit, or found harm.

We take the reviewers' own risk-of-bias and GRADE statements where they exist, and otherwise judge from study size, design, consistency, directness and whether a product matches what is sold. Many publications do not make evidence high. Method note: We searched PubMed, the EU herbal monograph and assessment report, LactMed and other regulators' pages, and recorded each study's design, people, product and result as reported. Only abstracts were read for most studies; the EU documents were read in full. Some sources (the original 1996 Awang letter beyond its title, Commission E, WHO, ESCOP, FDA, NCCIH and LiverTox) could not be read and are marked not verified or not found. Certainty ratings for many uses are the compiler's own reading, not formal grades. No study is cited that we could not verify.

Study library: every study we checked 53
StudyDesignPeopleProduct, dose, lengthResult
Amaryan 2003
Double-blind, placebo-controlled, randomized, pilot clinical trial of ImmunoGuard--a standardized fixed combination of Andrographis paniculata Nees, with Eleutherococcus senticosus Maxim, Schizandra chinensis Bail. and Glycyrrhiza glabra L. extracts in patients with Familial Mediterranean Fever.
Phytomedicine · PMID 12809357 · DOI
Controlled trial
24
Children aged 3 to 15 with Familial Mediterranean Fever
ImmunoGuard: Andrographis paniculata with Eleutherococcus senticosus, Schisandra chinensis and Glycyrrhiza glabra (licorice) extracts
combination 12 tablets a day (andrographolide 48 mg/day) 1 month · vs Placebo
All three attack features improved with the combination compared with placebo; severity improved most. Labelled a pilot.
Attack duration, frequency, severity improved vs placebo
Methods, limits and funding

Outcomes: Duration, frequency and severity of fever attacks

Limitations: A four-herb mix that includes licorice; 24 children; pilot. Numbers not in the abstract.

Read: abstract

Aslanyan 2010
Double-blind, placebo-controlled, randomised study of single dose effects of ADAPT-232 on cognitive functions.
Phytomedicine · PMID 20374974 · DOI
Controlled trial
40
Healthy women aged 20 to 68 who felt long-term stress, tested after a tiring Stroop task
ADAPT-232: fixed combination of Rhodiola rosea, Schisandra chinensis and Eleutherococcus senticosus extracts
combination (parts not stated in abstract) One 270 mg tablet, single dose Single dose, tested 2 hours later · vs Placebo
The ADAPT-232 group had better attention, speed and accuracy scores two hours after the dose than placebo (P < 0.05), and a tendency to fewer errors. Minor side effects (sleepiness, cold extremities) occurred in both groups.
Significant difference in d2 test scores (P < 0.05)
Methods, limits and funding

Outcomes: Attention, speed and accuracy on the d2 test of attention

Limitations: A three-herb combination, so the result cannot be credited to Eleutherococcus. Single dose, 40 women, pilot (phase IIa).

Funding and conflicts: Funding not stated in the abstract.

Read: abstract

Awang 1996
Siberian ginseng toxicity may be case of mistaken identity.
CMAJ · PMID 8964001
Comment
Letter commenting on the McRae case report Siberian ginseng products
unspecified
PubMed carries only the title and a short reference list (no abstract). The title says the toxicity may be a case of mistaken identity. The Periploca explanation comes from the EMA assessment report, which cites this letter.
Methods, limits and funding

Outcomes: Possible product mix-up

Limitations: NOT verified beyond the title and reference list: no abstract or full text was read.

Read: title-only

Bang 2015
Clinical effect of a polysaccharide-rich extract of Acanthopanax senticosus on alcohol hangover.
Pharmazie · PMID 26012258
Controlled trial
Healthy adults given alcohol (crossover) Polysaccharide-rich extract of Acanthopanax senticosus (PEA)
unspecified Before and after a drinking session · vs Placebo (crossover)
Blood alcohol was unchanged. Hangover items (tired, headache, dizziness, stomachache, nausea) and the total score improved. The rise in glucose disturbance and CRP caused by alcohol was reduced.
Hangover total score improved (values not given)
Methods, limits and funding

Outcomes: Blood alcohol level, Acute Hangover Scale, glucose, CRP

Limitations: Sample size and numbers are not in the abstract. One drinking session.

Read: abstract

Barth 2015
Antitussive effect of a fixed combination of Justicia adhatoda, Echinacea purpurea and Eleutherococcus senticosus extracts in patients with acute upper respiratory tract infection: A comparative, randomized, double-blind, placebo-controlled study.
Phytomedicine · PMID 26598919 · DOI
Controlled trial
177
Adults aged 18 to 65 with acute upper respiratory infection (cough)
Kan Jang oral solution: Justicia adhatoda leaf, Echinacea purpurea root and Eleutherococcus senticosus root
leaf + root + root 30 mL/day (0.03 mg/mL eleutherosides B and E) 5 days · vs Placebo and bromhexine
Kan Jang and bromhexine relieved cough more than placebo. On days 3 and 4 improvement was faster with Kan Jang. Well tolerated.
Cough relief better than placebo
Methods, limits and funding

Outcomes: Cough frequency

Limitations: A three-herb mix; the abstract gives no numbers.

Read: abstract

Cicero 2004
Effects of Siberian ginseng (Eleutherococcus senticosus maxim.) on elderly quality of life: a randomized clinical trial.
Arch Gerontol Geriatr Suppl · PMID 15207399 · DOI
Controlled trial
20
Elderly people (65+) with high blood pressure who were taking digitalis (digoxin)
Eleutherococcus senticosus dry extract
unspecified 300 mg/day 8 weeks · vs Placebo
At 4 weeks the social functioning score was higher on the extract (P = 0.02); this did not persist at 8 weeks. No adverse events in either group. No significant difference in blood pressure control or digoxin levels. 70% of the extract group guessed they were on active treatment, against 20% of placebo (P < 0.05).
Social functioning higher at week 4 only (P = 0.02)
Methods, limits and funding

Outcomes: Quality of life (SF-36v2) at baseline, 4 and 8 weeks; digoxin level and blood pressure checks

Limitations: Only 20 people (10 per group). Many scales were tested. Blinding may have been imperfect (more people on extract guessed correctly). Effect faded by week 8.

Read: abstract

Dasgupta 2003
Effect of Asian and Siberian ginseng on serum digoxin measurement by five digoxin immunoassays. Significant variation in digoxin-like immunoreactivity among commercial ginsengs.
Am J Clin Pathol · PMID 12580002 · DOI
Lab study
in-vitro
Lab testing of 5 digoxin blood tests; mice; patient serum pools Asian and Siberian ginseng products (3 Asian, 3 Siberian)
unspecified · vs Digoxin-free and digoxin-containing serum
Some Siberian ginseng products (a liquid extract and one capsule) showed apparent digoxin activity with the FPIA test. Mice fed ginseng also showed it. Serum from digoxin patients mixed with ginseng gave falsely raised values with FPIA and falsely lowered values with the MEIA test. No interference was seen with 3 other digoxin tests.
False highs (FPIA) or lows (MEIA) in some tests; none in 3 other tests
Methods, limits and funding

Outcomes: Interference with digoxin immunoassays

Limitations: Lab study with added ginseng, not patients taking ginseng. Products varied a lot.

Read: abstract

Dasgupta 2008
Effect of Asian ginseng, Siberian ginseng, and Indian ayurvedic medicine Ashwagandha on serum digoxin measurement by Digoxin III, a new digoxin immunoassay.
J Clin Lab Anal · PMID 18623124 · DOI
Lab study
in-vitro
Lab testing of the Digoxin III assay Asian ginseng, Siberian ginseng and ashwagandha supplements
unspecified · vs Digoxin-free and digoxin pool
Modest apparent digoxin (0.31 to 0.57 ng/mL) in drug-free serum with all three herbs on Digoxin III, with little on the Tina-quant assay. In digoxin pools the herbs gave falsely raised values; for example Asian ginseng raised one by 48.2%.
Modest false highs on Digoxin III
Methods, limits and funding

Outcomes: Interference with a newer digoxin assay

Limitations: Lab study. The 48.2% example was for Asian ginseng, not Siberian.

Read: abstract

Dasgupta 2011
Effect of Chinese medicines Chan Su, Asian ginseng, Siberian ginseng, and American ginseng on a new digoxin immunoassay based on luminescent oxygen channeling technology.
Ther Drug Monit · PMID 21860344 · DOI
Lab study
in-vitro
Lab testing of the LOCI digoxin assay Chan Su, Asian, Siberian and American ginseng
unspecified · vs Serum pools
Chan Su (a Chinese medicine) interfered clearly. The ginsengs, including Siberian ginseng, showed negligible effects at clinically relevant concentrations.
No measurable interference from ginsengs
Methods, limits and funding

Outcomes: Interference with the LOCI digoxin test

Limitations: Lab study.

Read: abstract

Donovan 2003
Siberian ginseng (Eleutheroccus senticosus) effects on CYP2D6 and CYP3A4 activity in normal volunteers.
Drug Metab Dispos · PMID 12695337 · DOI
Controlled trial
12
Healthy volunteers
Standardised Siberian ginseng extract
unspecified 485 mg twice daily 14 days · vs Before-and-after (baseline vs treatment)
No significant change in either enzyme.
No effect
Methods, limits and funding

Outcomes: Drug-metabolising enzyme activity (CYP2D6 via dextromethorphan; CYP3A4 via alprazolam)

Limitations: Healthy volunteers, single product, 12 people.

Read: abstract

Dowling 1996
Effect of Eleutherococcus senticosus on submaximal and maximal exercise performance.
Med Sci Sports Exerc · PMID 8778554 · DOI
Controlled trial
20
Highly trained distance runners
Eleutherococcus senticosus extract (ESML)
unspecified 3.4 mL extract a day 6 weeks of supplement within an 8-week study (tests every 2 weeks, plus 2 weeks after stopping) · vs Placebo
No significant differences between extract and placebo on any measure, including time to exhaustion and lactate. The authors say the data do not support an ergogenic (performance-boosting) effect.
No difference on any measure
Methods, limits and funding

Outcomes: Heart rate, oxygen use, breathing, perceived effort and lactate during a 10-minute race-pace run and a maximal treadmill test

Limitations: Only 20 well-trained runners; one extract.

Read: abstract

Eschbach 2000
The effect of siberian ginseng (Eleutherococcus senticosus) on substrate utilization and performance.
Int J Sport Nutr Exerc Metab · PMID 11099371 · DOI
Controlled trial
9
Highly trained male endurance cyclists (crossover)
Siberian ginseng (Eleutherococcus senticosus)
unspecified 1,200 mg a day 7 days before each trial · vs Placebo (crossover)
No significant differences. Time trial 18.10 +/- 0.42 min on extract vs 17.83 +/- 0.47 min on placebo (P > 0.05). Fuel use during steady cycling was unchanged.
No significant difference
Methods, limits and funding

Outcomes: Fuel use, oxygen use, heart rate, lactate and glucose during 120 minutes of cycling, then a 10-km time trial

Limitations: Only 9 men; only 7 days of use.

Read: abstract

Fukada 2016
Antiedema effects of Siberian ginseng in humans and its molecular mechanism of lymphatic vascular function in vitro.
Nutr Res · PMID 27333960 · DOI
Controlled trial
50
50 healthy women (two-way crossover)
Siberian ginseng powder
unspecified Single ingestion; swelling checked at 2 and 4 hours · vs Control (crossover)
Lower-leg swelling was significantly reduced at 2 and 4 hours after ingestion. The paper also reports lab work on lymph-vessel cells.
Swelling reduced vs control at 2 and 4 hours
Methods, limits and funding

Outcomes: Lower-leg swelling (edema)

Limitations: Short-term, healthy women; the authors are from a cosmetics company research centre.

Funding and conflicts: Both authors work at Shiseido Research Center. Industry-linked.

Read: abstract

Gaffney 2001
The effects of Eleutherococcus senticosus and Panax ginseng on steroidal hormone indices of stress and lymphocyte subset numbers in endurance athletes.
Life Sci · PMID 11798012 · DOI
Controlled trial
Competitive club-level endurance athletes in normal training Eleutherococcus senticosus 33% ethanol extract (or Panax ginseng, or placebo)
root (extract equal to 4 g dried root a day per the abstract) 8 mL/day 6 weeks · vs Placebo (and Panax ginseng arm)
In the Eleutherococcus group TCR fell 28.7% (0.0464 to 0.0331, P = 0.03), mainly because cortisol tended to rise by 31% (P = 0.07, not significant); testosterone fell 7% (P = 0.36, not significant). No significant change in the Panax ginseng group. None of the immune cell counts changed. The authors read this as Eleutherococcus raising rather than lowering stress hormone indices.
TCR -28.7% (P = 0.03); cortisol +31% (P = 0.07)
Methods, limits and funding

Outcomes: Cortisol, testosterone, testosterone-to-cortisol ratio (TCR) and lymphocyte subsets

Limitations: The abstract does not give group sizes. The cortisol change was not significant. Athletes in training are not the same as people with long-term stress.

Read: abstract

Gaffney 2001
Panax ginseng and Eleutherococcus senticosus may exaggerate an already existing biphasic response to stress via inhibition of enzymes which limit the binding of stress hormones to their receptors.
Med Hypotheses · PMID 11388770 · DOI
Hypothesis
in-vitro
None (theory paper) Eleutherococcus senticosus and Panax ginseng
root
Proposes that Eleutherococcus may inhibit the enzyme COMT, which breaks down stress hormones, leading to a two-way effect on the stress response.
Methods, limits and funding

Outcomes: Proposed mechanism for a two-way stress response

Limitations: A proposed idea, not tested in this paper.

Read: abstract

Gafner 2023
Botanical Ingredient Forensics: Detection of Attempts to Deceive Commonly Used Analytical Methods for Authenticating Herbal Dietary and Food Ingredients and Supplements.
J Nat Prod · PMID 36716213 · DOI
Review
n/a
Review of botanical adulteration methods Many botanicals, including eleuthero root extracts
root
The review lists eleuthero (Eleutherococcus senticosus) root among extracts at risk of adulteration; details are not in the abstract.
Methods, limits and funding

Outcomes: Which botanical ingredients are at risk of adulteration

Limitations: Only the abstract was read; the specific eleuthero findings are not given there.

Read: abstract

Ghamari 2020
Vitamin E and ginseng supplementation to enhance female sexual function: a randomized, double-blind, placebo-controlled, clinical trial.
Women Health · PMID 32893745 · DOI
Controlled trial
69
Women with sexual dysfunction (69 enrolled; 31 per group completed)
Vitamin E 100 IU plus Korean ginseng 67 mg plus Siberian ginseng 40 mg (combined supplement)
combination As stated 6 weeks · vs Placebo
Total score did not differ between supplement and placebo. The supplement did better than placebo on desire and satisfaction.
Desire and satisfaction better; total score not
Methods, limits and funding

Outcomes: Female Sexual Function Index (FSFI)

Limitations: Three-ingredient supplement; many dropouts; the Siberian ginseng dose was small.

Read: abstract

Guo 2014
Effects of eleutheroside B and eleutheroside E on activity of cytochrome P450 in rat liver microsomes.
BMC Complement Altern Med · PMID 24383621 · DOI
Laboratory research
in-vitro
Rat liver microsomes Eleutheroside B and eleutheroside E (isolated)
· vs Control
Weak inhibition of CYP2C9 and CYP2E1; no effect on CYP2D6 or CYP3A4. IC50 for CYP2E1 was 193.20 and 188.36 micromolar for B and E; for CYP2C9 595.66 and 261.82 micromolar.
Weak inhibition at high concentrations
Methods, limits and funding

Outcomes: CYP2C9, CYP2D6, CYP2E1, CYP3A4 activity

Limitations: Rat enzymes and isolated compounds, not human or whole herb.

Read: abstract

Hartz 2004
Randomized controlled trial of Siberian ginseng for chronic fatigue.
Psychol Med · PMID 14971626 · DOI
Controlled trial
96
Adults with unexplained fatigue for at least 6 months (96 randomised, 76 gave 2-month data)
Siberian ginseng (Eleutherococcus senticosus) standardised root extract
root 2 months · vs Placebo
Fatigue fell a lot in both groups. The difference between treatment and placebo was not statistically significant in the full group. In pre-planned subgroups, those with less severe fatigue (45 people) did better on Siberian ginseng at 2 months (P = 0.04, not adjusted for multiple comparisons); those with fatigue for 5 years or more (41 people) P = 0.09.
Overall no significant difference; subgroup P = 0.04 (not adjusted)
Methods, limits and funding

Outcomes: Change in a fatigue measure at 1 and 2 months

Limitations: The authors concluded overall efficacy was not demonstrated. Subgroup findings are exploratory. About 20% of people did not give 2-month data. Dose and extract details come from the EMA report, not the abstract.

Read: abstract

Hwang 2009
The effects of Acanthopanax senticosus extract on bone turnover and bone mineral density in Korean postmenopausal women.
J Bone Miner Metab · PMID 19452124 · DOI
Controlled trial
81
Postmenopausal Korean women with osteopenia or osteoporosis under 65
Acanthopanax senticosus extract plus calcium
unspecified (extract) 3 g/day extract plus 500 mg/day calcium 6 months · vs Calcium alone (500 mg/day)
Serum osteocalcin was higher in the extract group (P = 0.041). Bone mineral density on DXA scan did not change significantly. No difference in adverse events.
Osteocalcin higher (P = 0.041); BMD unchanged
Methods, limits and funding

Outcomes: Bone turnover markers and bone mineral density

Limitations: Control had calcium only (no placebo extract). A bone marker is not a fracture outcome.

Read: abstract

Jacquet 2015
Burnout: evaluation of the efficacy and tolerability of TARGET 1® for professional fatigue syndrome (burnout).
J Int Med Res · PMID 25537278 · DOI
Controlled trial
87
Workers in contact with patients, students or clients with burnout (Burnout Measure Scale score of 4 or more)
TARGET 1: dietary supplement combining casozepine, taurine, Eleutherococcus senticosus and extramel
unspecified 12 weeks · vs Placebo
Both groups improved on several scores. The supplement group improved on all five scores and improved more than placebo. Exact values are not in the abstract.
Greater improvement than placebo on all scores (values not given)
Methods, limits and funding

Outcomes: Burnout Measure Scale (BMS-10); Maslach Burnout Inventory (MBI-HSS); Beck Depression Inventory

Limitations: A four-ingredient product, so the result cannot be credited to Eleutherococcus. The placebo group also improved significantly. Numbers are not in the abstract.

Funding and conflicts: Funding not stated in the abstract.

Read: abstract

Jia 2021
A review of Acanthopanax senticosus (Rupr and Maxim.) harms: From ethnopharmacological use to modern application.
J Ethnopharmacol · PMID 33212178 · DOI
Review
n/a
Review of Acanthopanax senticosus A. senticosus
unspecified
The review says A. senticosus is safe and has no significant adverse effects at normal doses.
Methods, limits and funding

Outcomes: Overview including toxicology

Limitations: Narrative review; only the abstract was read; it is a statement, not a safety study.

Read: abstract

Kaloeva 1986
[Effect of the glycosides of Eleutherococcus senticosus on the hemodynamic indices of children with hypotensive states].
Farmakol Toksikol · PMID 3770180
Clinical
Children aged 7 to 10 with neurocirculatory low blood pressure Eleutherococcus senticosus fluid extract (extractum eleutherococci fluidum)
unspecified
Both systolic and diastolic pressure, low before treatment, rose significantly and total peripheral resistance increased. Symptoms improved.
Blood pressure rose
Methods, limits and funding

Outcomes: Blood pressure and symptoms

Limitations: A 1986 Russian-language abstract only; design, size and controls are not given.

Read: abstract

Kawano 2024
Feasibility and Safety of Food Containing Acanthopanax senticosus for Treating Patients with Cancer-Related Fatigue.
Palliat Med Rep · PMID 39281184 · DOI
Single arm feasibility
15
Adults with cancer-related fatigue
Food (drink) containing Acanthopanax senticosus Harms (ASH)
unspecified 28 days
Only 7 of 15 people finished. The 4 people with milder fatigue at the start (Brief Fatigue Inventory under 5.5) had a lower fatigue score. The antioxidant-to-oxidant ratio rose but not significantly (P = 0.063). No adverse events attributable to the drink.
7 of 15 completed; antioxidant ratio P = 0.063
Methods, limits and funding

Outcomes: Completion rate (primary); Brief Fatigue Inventory; oxidative stress markers; adverse events

Limitations: No control group, very small, half dropped out. Feasibility study only.

Read: abstract

Kos 2025
Eleutherococcus senticosus (Acanthopanax senticosus): An Important Adaptogenic Plant.
Molecules · PMID 40572479 · DOI
Review
Narrative review of Eleutherococcus senticosus E. senticosus (rhizome and bark used medicinally)
root/rhizome/bark
A broad review of chemistry and pharmacology. It says the plant is used in traditional Chinese, Korean and Japanese medicine and is endangered in some areas.
Methods, limits and funding

Outcomes: Overview of composition, traditional roles, pharmacology

Limitations: Narrative review; only the abstract was read. It does not grade the clinical evidence.

Funding and conflicts: No conflicts declared

Read: abstract

Kuo 2010
The effect of eight weeks of supplementation with Eleutherococcus senticosus on endurance capacity and metabolism in human.
Chin J Physiol · PMID 21793317 · DOI
Controlled trial
9
Recreationally trained young men (crossover)
Eleutherococcus senticosus
root or rhizome (per EMA report); extract 800 mg a day 8 weeks (4-week washout between) · vs Starch placebo (crossover)
VO2 peak rose 12% (P < 0.05); endurance time improved 23% (P < 0.05); the highest heart rate rose 4%. At 30 minutes, free fatty acids were higher and glucose lower (both P < 0.05) on the extract.
VO2 peak +12%; endurance time +23%
Methods, limits and funding

Outcomes: Time to exhaustion at 75% VO2 peak, VO2 peak, heart rate, blood free fatty acids and glucose

Limitations: Only 9 participants. The EMA assessment says the number is too small to show clinical efficacy. Results conflict with the two larger null trials.

Read: abstract

LactMed (NLM/NICHD) 2024
Eleuthero.
Drugs and Lactation Database (LactMed), NICHD · PMID 30000865
Authoritative guidance
Breastfeeding mothers and infants (drug database entry) Eleuthero (Eleutherococcus senticosus) as a dietary supplement
unspecified
LactMed (updated 2024-09-15): no data on safety or efficacy in nursing mothers or infants. In general well tolerated. May increase blood pressure, bleeding and blood sugar. Breast tenderness has been reported. Most sources recommend against use during breastfeeding because of a lack of safety data. No good human evidence supports its common uses.
Methods, limits and funding

Outcomes: Safety in breastfeeding

Limitations: Database entry, not a study; the statements are summaries of other sources. The entry was read in full on PubMed (no author names or journal are listed).

Read: abstract

Lau 2019
A review on the immunomodulatory activity of Acanthopanax senticosus and its active components.
Chin Med · PMID 31388349 · DOI
Review
in-vitro
Review of immune-regulating activity of Acanthopanax senticosus Aqueous and ethanol extracts and compounds
root, rhizome, stem
Isofraxidin, syringin and eleutheroside E modulate immune function in lab studies, but the whole aqueous extract was the most potent. The review argues the aqueous extract rather than the ethanol extract should be used for immune effects.
Methods, limits and funding

Outcomes: Immune effects in lab studies

Limitations: Lab-based review, no human trial data. Only the abstract was read.

Funding and conflicts: No competing interests declared.

Read: abstract

Li 2022
Pharmacological effects of Eleutherococcus senticosus on the neurological disorders.
Phytother Res · PMID 35844057 · DOI
Review
in-vitro
Review of E. senticosus and nerve-related conditions Eleutherococcus senticosus
root
Summarises traditional use and mostly lab and animal findings on antioxidant, anti-inflammatory and nerve-growth effects.
Methods, limits and funding

Outcomes: Summary of effects on fatigue, depression, Alzheimer disease, Parkinson disease, brain blood-flow loss

Limitations: Narrative review, mostly lab and animal work; only the abstract was read.

Read: abstract

McRae 1996
Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng.
CMAJ · PMID 8705908
Case report
1
74-year-old man taking digoxin for many years
Siberian ginseng (product not authenticated)
unspecified · vs Own baseline (stop and restart)
Digoxin level was high with no signs of toxicity. It returned to the usual range when Siberian ginseng was stopped, rose again when restarted, and fell again when stopped. It is unclear whether a plant component was read as digoxin by the test, interfered with elimination, or was converted.
One patient: high level on ginseng, normal off it
Methods, limits and funding

Outcomes: Serum digoxin level

Limitations: One patient. The product was not tested for eleutherosides, so it may not have been Eleutherococcus (the EMA report says it may have been adulterated with Periploca sepium).

Read: abstract

Narimanian 2005
Randomized trial of a fixed combination (KanJang) of herbal extracts containing Adhatoda vasica, Echinacea purpurea and Eleutherococcus senticosus in patients with upper respiratory tract infections.
Phytomedicine · PMID 16121513 · DOI
Controlled trial
Adults with non-complicated acute respiratory infections KanJang: fixed combination of Echinacea purpurea, Adhatoda vasica and Eleutherococcus senticosus extracts
combination · vs Echinacea plus Eleutherococcus mixture (double blind) and bromhexine (open)
Several symptoms improved more with KanJang than with bromhexine. Recovery time was 2 days shorter in the KanJang and the Echinacea mixture groups than with bromhexine. No adverse reactions reported by completers.
Recovery 2 days shorter than with bromhexine
Methods, limits and funding

Outcomes: Cough, mucus, nasal congestion, general feeling of sickness; recovery time

Limitations: A three-herb mix; no placebo; one comparison was open-label. Numbers not in the abstract.

Read: abstract

Narimanian 2005
Impact of Chisan (ADAPT-232) on the quality-of-life and its efficacy as an adjuvant in the treatment of acute non-specific pneumonia.
Phytomedicine · PMID 16323290 · DOI
Controlled trial
60
Adults aged 18 to 65 with acute non-specific pneumonia, all on standard antibiotics
Chisan (ADAPT-232): Rhodiola rosea, Schisandra chinensis and Eleutherococcus senticosus extracts
combination Twice daily 10 to 15 days · vs Placebo (added to standard treatment)
Antibiotic treatment needed was 2 days shorter with Chisan. Quality-of-life scores were higher, significantly so on day 5 after recovery.
2 days shorter antibiotic treatment
Methods, limits and funding

Outcomes: Duration of antibiotic treatment, mental performance, quality of life (WHOQOL-Bref)

Limitations: A three-herb mix; 60 patients; pilot.

Read: abstract

Oh 2020
The fruit of Acanthopanax senticosus Harms improves arterial stiffness and blood pressure: a randomized, placebo-controlled trial.
Nutr Res Pract · PMID 32765813 · DOI
Controlled trial
76
Healthy adults with at least 2 of: borderline high blood pressure, smoking, borderline blood fats
Acanthopanax senticosus Harms FRUIT extract
fruit 500 mg/day (low) or 1,000 mg/day (high) 12 weeks · vs Placebo
Low-dose group had a greater drop in systolic blood pressure than placebo (-7.7 vs +0.1 mmHg, P = 0.044) and in baPWV (-98.7 vs +31.3 cm/s, P = 0.007). The abstract reports benefits only for the low dose.
Systolic BP -7.7 vs +0.1 mmHg; baPWV -98.7 vs +31.3 cm/s
Methods, limits and funding

Outcomes: Arterial stiffness (baPWV), flow-mediated dilation, carotid thickness, blood pressure

Limitations: This used the FRUIT, not the root. 76 people. Only the lower dose showed an effect.

Funding and conflicts: Authors report no conflicts of interest. Registered KCT0001072.

Read: abstract

Patyra 2025
Eleutherococcus root: a comprehensive review of its phytochemistry and pharmacological potential in the context of its adaptogenic effect.
Front Pharmacol · PMID 41235111 · DOI
Review
Review of phytochemistry and clinical evidence of Eleutherococcus root Eleutherococcus senticosus root preparations
root
The review says the EMA accepts root for symptoms of asthenia such as fatigue and weakness, but the main problem is the lack of robust clinical evidence. Trials are very different from each other and of low quality, and preparations are poorly standardised, which makes it impossible to judge effectiveness.
Methods, limits and funding

Outcomes: Critical review of clinical trials for symptoms of asthenia

Limitations: Narrative review. Only the abstract was read.

Funding and conflicts: No conflict of interest declared (one author is a Frontiers editorial board member).

Read: abstract

Rasmussen 2012
Dietary supplements and hypertension: potential benefits and precautions.
J Clin Hypertens (Greenwich) · PMID 22747620 · DOI
Review
Review of dietary supplements and blood pressure Several supplements including Siberian ginseng
unspecified
Found 4 supplements with possible benefit (coenzyme Q10, fish oil, garlic, vitamin C) and 4 consistently associated with raised blood pressure: ephedra, Siberian ginseng, bitter orange, licorice.
Methods, limits and funding

Outcomes: Which supplements may help or raise blood pressure

Limitations: Only the abstract was read; the evidence behind the Siberian ginseng statement is not given there. The EMA later found no clinical-trial support for a blood-pressure contraindication.

Read: abstract

Ruhsam 2018
Authentication of Eleutherococcus and Rhodiola herbal supplement products in the United Kingdom.
J Pharm Biomed Anal · PMID 29154110 · DOI
Authentication study
n/a
25
25 Siberian ginseng and 14 roseroot supplements sold in the UK
DNA barcoding of Siberian ginseng supplements
unspecified
All 25 Siberian ginseng supplements contained E. senticosus, but 36% also contained another Eleutherococcus species. The authors conclude substitution or mixing is common in the two popular supplements studied.
36% contained another Eleutherococcus species
Methods, limits and funding

Outcomes: Whether the labelled species was in the product

Limitations: UK market, small sample, DNA test shows presence not amount.

Read: abstract

Sato 2024
Effects of continuous supplementation of Acanthopanax senticosus Harms on the cardiac autonomic function of community-dwelling elderly individuals during resting and standing tests: a randomized controlled trial.
Front Cardiovasc Med · PMID 38525193 · DOI
Controlled trial
28
Community-dwelling older adults (average 72.5 years)
Acanthopanax senticosus Harms (ASH) supplement
unspecified 4 weeks · vs Placebo
Group-by-time effects were significant for CVRR, HF and the change in LF/HF ratio. After 4 weeks, CVRR, HF, LF/HF ratio, systolic blood pressure, heart rate and the standing changes improved significantly in the ASH group only. Numbers are not in the abstract.
Significant group-time interaction for CVRR, HF and delta LF/HF
Methods, limits and funding

Outcomes: Heart-rate variability and blood pressure while seated and on standing (cardiac autonomic function)

Limitations: Only 28 people. Heart-rate variability is a lab measure, not a symptom or outcome. Which part of the plant and how it was made are not in the abstract.

Funding and conflicts: Two authors are employees of Sun Chlorella Corporation, which supplied information about the supplements. Industry-linked.

Read: abstract

Schaffler 2013
No benefit adding eleutherococcus senticosus to stress management training in stress-related fatigue/weakness, impaired work or concentration, a randomized controlled study.
Pharmacopsychiatry · PMID 23740477 · DOI
Controlled trial
144
Adults with stress-related fatigue or weakness, reduced work capacity or concentration
Eleutherococcus senticosus root extract, alone, with 2-day stress management training (SMT), or SMT alone
root 120 mg/day root extract (as in the abstract) 8 weeks (checked at 2 and 8 weeks) · vs Three active arms (extract, SMT, both); no placebo-only arm named in the abstract
Almost all measures improved over time with no differences between groups. Adding the extract to stress training gave no extra benefit (differences, if any, negligible). Cortisol awakening response was lower at week 2 in all groups, again without group differences. All treatments were well tolerated.
No group differences on almost all measures
Methods, limits and funding

Outcomes: Cognitive tests, stress, fatigue, mood, sleep, quality of life, cortisol awakening response

Limitations: No placebo-only arm, so improvement over time cannot be credited to any treatment. Registered as DRKS00000692.

Funding and conflicts: The lead author is affiliated with a company (HPR Dr. Schaffler GmbH); funder not stated in the abstract.

Read: abstract

Sievenpiper 2004
Decreasing, null and increasing effects of eight popular types of ginseng on acute postprandial glycemic indices in healthy humans: the role of ginsenosides.
J Am Coll Nutr · PMID 15190050 · DOI
Controlled trial
12
12 healthy adults (crossover)
Eight kinds of ginseng, including Siberian ginseng (Eleutherococcus)
unspecified 3 g, 40 minutes before a 75 g sugar-drink test Single test day each · vs Two placebos
Siberian ginseng raised blood glucose at 90 and 120 minutes and total glucose over the test (AUC) compared with placebo (P < 0.05). Asian ginseng also raised glucose; American and Vietnamese ginseng tended to lower it. Numbers for Siberian ginseng alone are not in the abstract.
Higher glucose (P < 0.05)
Methods, limits and funding

Outcomes: Blood glucose and insulin over 2 hours after a sugar drink

Limitations: Single dose in 12 healthy people; not people with diabetes.

Read: abstract

Siwek 2023
Harder, better, faster, stronger? Retrospective chart review of adverse events of interactions between adaptogens and antidepressant drugs.
Front Pharmacol · PMID 37829299 · DOI
Chart review
1816
Adverse event reports from a Polish drug-safety centre (1,816 reports)
Adaptogens taken with antidepressants
unspecified
Adaptogens were involved in 9% of reports. For Eleutherococcus senticosus the paper lists: upper gastrointestinal bleeding with duloxetine, nosebleed with paroxetine, vaginal bleeding with sertraline, and irritability, agitation, headache and dizziness with agomelatine. 30 causal reports in total across all adaptogens.
Bleeding events with SSRIs/SNRIs in single cases
Methods, limits and funding

Outcomes: Adverse events in adaptogen plus antidepressant users

Limitations: Reports and a retrospective chart review; cannot show how common it is or prove cause. The abstract does not give how many Eleutherococcus reports there were.

Read: abstract

Szołomicki 2000
The influence of active components of Eleutherococcus senticosus on cellular defence and physical fitness in man.
Phytother Res · PMID 10641044 · DOI
Controlled trial
50
50 healthy volunteers; 20 men had exercise testing
Taiga Wurzel (Eleutherococcus senticosus preparation) compared with Echinacea
unspecified 25 drops three times a day 30 days · vs Echinacea preparation (not placebo); 35 vs 15 people
Total cholesterol, LDL, triglycerides and glucose changed in the Taiga Wurzel group but not in the Echinacea group (the abstract does not state which way). A higher oxygen plateau was seen on the Eleutherococcus preparation in the exercise test.
Changes in lipids and glucose (direction and size not given in abstract)
Methods, limits and funding

Outcomes: Blood cholesterol, triglycerides, glucose, blood cells; exercise oxygen plateau

Limitations: No placebo; Echinacea is a different herb; direction and numbers are not in the abstract; unequal group sizes.

Read: abstract

Takahashi 2010
Effects of Acanthopanax senticosus HARMS extract on drug transport in human intestinal cell line Caco-2.
J Nat Med · PMID 20091240 · DOI
Laboratory research
in-vitro
Human intestinal Caco-2 cell line Acanthopanax senticosus extract
unspecified · vs Control cells
The extract increased movement of digoxin across the cell layer and reduced P-glycoprotein transport of a test dye, which means it may block this drug-pump. It decreased movement of the drug cephalexin through a peptide transporter.
P-gp and peptide transporter activity suppressed in cells
Methods, limits and funding

Outcomes: Drug transporter (P-glycoprotein) activity

Limitations: Cell study only; no human data.

Read: abstract

Tohda 2020
Combined Treatment with Two Water Extracts of Eleutherococcus senticosus Leaf and Rhizome of Drynaria fortunei Enhances Cognitive Function: A Placebo-Controlled, Randomized, Double-Blind Study in Healthy Adults.
Nutrients · PMID 31979283 · DOI
Controlled trial
Healthy adults (number not given in the abstract) Water extracts of Eleutherococcus senticosus LEAF combined with Drynaria fortunei rhizome
leaf (E. senticosus) + rhizome (Drynaria) 12 weeks · vs Placebo
The combined extracts raised the figure-recall subscore compared with placebo (P = 0.045). Within-group improvements were seen in language (P = 0.040), semantic fluency (P = 0.021) and anxiety/uncertainty score (P = 0.022). No adverse effects were observed.
Figure recall higher than placebo (P = 0.045); other gains were within-group only
Methods, limits and funding

Outcomes: RBANS neuropsychological test; anti-stress scores

Limitations: This used the LEAF of the plant (not the root) in a two-herb combination. Sample size is not in the abstract. Many tests were run, and most positive findings were within-group, not versus placebo.

Funding and conflicts: One author affiliation is a company (Resilio Co. Ltd.); the authors state no conflict of interest and that funders had no role.

Read: abstract

Weng 2007
Comparison of the Addition of Siberian Ginseng (Acanthopanax senticosus) Versus Fluoxetine to Lithium for the Treatment of Bipolar Disorder in Adolescents: A Randomized, Double-Blind Trial.
Curr Ther Res Clin Exp · PMID 24683218 · DOI
Controlled trial
76
Adolescents aged 12 to 17 with bipolar disorder, all taking lithium
Acanthopanax senticosus (Eleutherococcus senticosus) added to lithium, versus fluoxetine added to lithium
root (eleutherosides and polysaccharides, per the abstract) 6 weeks · vs Fluoxetine plus lithium (no placebo arm)
Response was 67.6% with the herb versus 71.8% with fluoxetine; remission 51.4% versus 48.7%. No significant difference between groups. Three people on fluoxetine switched to mania, none on the herb. Side effects on the herb: nausea 2 (5.4%), rash 1 (2.7%), diarrhoea 1 (2.7%).
Response 67.6% vs 71.8%; remission 51.4% vs 48.7%; no group difference
Methods, limits and funding

Outcomes: Depression score (HAMD-17), mania score, response, remission, switching to mania, side effects

Limitations: No placebo group, so improvement cannot be credited to the herb. Single-country (China) study of 76 teenagers. Bipolar disorder needs specialist care.

Read: abstract

s-books-search-livertox
NCBI Bookshelf search for a LiverTox entry on eleuthero / Eleutherococcus
· Source
Reference database
n/a

Methods, limits and funding

Read: search

s-ema-eleutherococci-radix-page
EMA herbal medicine page: Eleutherococci radix
· Source
Authoritative guidance
n/a

Methods, limits and funding

Read: full-text

s-ema-hmpc-eleutherococcus-radix-ar
EMA/HMPC Assessment report on Eleutherococcus senticosus (Rupr. et Maxim.) Maxim., radix (EMA/HMPC/680615/2013)
· Source
Authoritative guidance
n/a

Methods, limits and funding

Read: full-text

s-ema-hmpc-eleutherococcus-radix-monograph
EMA/HMPC Community herbal monograph on Eleutherococcus senticosus (Rupr. et Maxim.) Maxim., radix (EMA/HMPC/680618/2013), 25 March 2014
· Source
Authoritative guidance
n/a

Methods, limits and funding

Read: full-text

s-gbif-eleutherococcus-senticosus
GBIF Backbone: Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. (usageKey 3035369)
· Source
Reference database
n/a

Methods, limits and funding

Read: api

s-gbif-periploca-sepium
GBIF Backbone: Periploca sepium Bunge (usageKey 5526185)
· Source
Reference database
n/a

Methods, limits and funding

Read: api

s-ncbi-taxonomy-eleutherococcus-senticosus
NCBI Taxonomy: Eleutherococcus senticosus (taxid 82096)
· Source
Reference database
n/a

Methods, limits and funding

Read: api

s-nccih-eleuthero-not-found
NCCIH: no eleuthero or Siberian ginseng health page found
· Source
Reference database
n/a

Methods, limits and funding

Read: search

s-pubchem-eleutherococcus-compounds
PubChem compound records: syringin, eleutheroside E, isofraxidin, chlorogenic acid, sesamin, beta-hederin, sitogluside, coniferaldehyde
· Source
Reference database
n/a

Methods, limits and funding

Read: api

What we do not know yet

  • What the evidence supports: nothing is rated above very low or mixed. The EU says none of the studies proves benefit in a defined condition.
  • What is uncertain: whether any benefit exists for tiredness, stress or endurance, and whether blood pressure and blood sugar go up or down.
  • What is missing: large well-run placebo-controlled trials of a standardised root extract, trials in people with diabetes or high blood pressure, and any human data in pregnancy, breastfeeding or hormone-sensitive cancers.
  • Most positive results come from mixed products (Kan Jang, ADAPT-232, TARGET 1), the fruit or the leaf, so cannot be credited to the root.
  • Digoxin: it is unresolved whether there is a true effect or only test interference and past product mix-ups.
  • Commission E, WHO, ESCOP, FDA, NCCIH and LiverTox: no primary page on eleuthero was read; NCCIH and LiverTox were not found.

How new research is added

New studies are found by a saved PubMed search and are placed in a review queue. A person reads each one before it changes any evidence rating or safety wording. New publications never change ratings automatically.

Lab markers

What changed in blood or saliva tests during trials. A changed number is not the same as feeling or being healthier, and we give no "normal ranges".

Hormonal 2

↕

Cortisol (stress hormone)

Mixed results in trials

A hormone from the adrenal glands that rises with stress.

Very low certainty
Results and what it means

Why it was measured

Adaptogens are said to modulate the stress response.

Statistical vs. clinical meaning

Neither trial shows a benefit that can be told apart from chance or from time.

Safety implication

Hormone changes in a lab test do not show symptom change.

StudyResultPeopleProduct
14Cortisol tended to rise 31% (P = 0.07, not significant); testosterone-to-cortisol ratio fell 28.7% (P = 0.03).Endurance athletes33% ethanol extract of E. senticosus, 6 weeks
38Cortisol awakening response was lower at week 2 in all groups, with no group differences.Adults with stress-related fatigue120 mg/day root extract, alone or with stress training

14 38

▼

Testosterone-to-cortisol ratio

Lowered in trials

A rough marker of whether the body is in 'build up' or 'break down' mode in athletes.

Very low certainty
Results and what it means

Why it was measured

Used in sport science as a training-stress marker.

Statistical vs. clinical meaning

One small study, mainly driven by a non-significant cortisol rise.

Safety implication

A falling ratio is usually read as more stress, not less.

StudyResultPeopleProduct
14Fell from 0.0464 to 0.0331 (-28.7%, P = 0.03) in the Eleutherococcus group; no change with Panax ginseng or placebo.Endurance athletesE. senticosus extract, 6 weeks

14

Metabolic 2

↕

Blood glucose

Mixed results in trials

Sugar in the blood.

Not enough evidence
Results and what it means

Why it was measured

Key for diabetes.

Statistical vs. clinical meaning

Opposite directions in different settings.

Safety implication

No data in diabetes.

StudyResultPeopleProduct
39Siberian ginseng raised glucose at 90 and 120 minutes and total glucose (AUC) after a sugar drink (P < 0.05)Healthy adults, n = 123 g Siberian ginseng, single dose
26Plasma glucose was lower at 30 min of cycling on the extract (P < 0.05)Recreationally trained men800 mg/day for 8 weeks

39 26

↕

Total cholesterol, LDL and triglycerides

Mixed results in trials

Blood fats.

Not enough evidence
Results and what it means

Why it was measured

Linked to heart disease risk.

Statistical vs. clinical meaning

Direction unknown.

Safety implication

Cannot interpret.

StudyResultPeopleProduct
41Total cholesterol, LDL, triglycerides and glucose changed in the Taiga Wurzel group; direction not stated in the abstractHealthy volunteersTaiga Wurzel 30 days

41

Inflammatory 1

▼

C-reactive protein (CRP)

Lowered in trials

A blood marker of inflammation.

Not enough evidence
Results and what it means

Why it was measured

Used here as a stress-on-the-body marker after alcohol.

Statistical vs. clinical meaning

One small crossover.

Safety implication

None.

StudyResultPeopleProduct
4The alcohol-induced change in CRP was reduced (numbers not in abstract)Healthy adults, crossoverPolysaccharide-rich extract

4

Organ function 1

●

Immune cell counts (T-cells, NK cells, B-cells)

No clear change in trials

Types of white blood cells.

Low certainty
Results and what it means

Why it was measured

Used to see whether the extract changes immunity.

Statistical vs. clinical meaning

Counts do not equal infection protection.

Safety implication

None.

StudyResultPeopleProduct
14No significant change or trend in any immune variableEndurance athletesE. senticosus extract, 6 weeks

14

Other 7

▲

Heart rate variability (CVRR, HF, LF/HF)

Raised in trials

The small beat-to-beat changes in heart rhythm that reflect the nervous system's balance.

Not enough evidence
Results and what it means

Why it was measured

Used as a lab marker of stress and ageing of the autonomic nervous system.

Statistical vs. clinical meaning

28 people and a lab marker only.

Safety implication

Statistical change; no symptom or outcome change shown.

StudyResultPeopleProduct
37CVRR, HF, LF/HF ratio and heart rate improved significantly in the ASH group only; group-time interaction significant for CVRR, HF and delta LF/HF (numbers not in abstract).Older adultsASH supplement, 4 weeks

37

●

Antioxidant-to-oxidant ratio (BAP/d-ROMs)

No clear change in trials

A blood test balance of antioxidant power against oxidant products.

Not enough evidence
Results and what it means

Why it was measured

Oxidative stress is higher in some cancer patients.

Statistical vs. clinical meaning

Not significant; no control group.

Safety implication

None.

StudyResultPeopleProduct
24Antioxidant potential ratio rose but not significantly (P = 0.063).Cancer-related fatigue, 15 peopleAcanthopanax senticosus drink, 28 days

24

▲

Oxygen use at peak effort (VO2 peak)

Raised in trials

The most oxygen the body can use during hard exercise.

Very low certainty
Results and what it means

Why it was measured

A standard measure of aerobic fitness.

Statistical vs. clinical meaning

Significant in a 9-person crossover; two other trials found no change in performance.

Safety implication

Fitness lab measure; not a health outcome.

StudyResultPeopleProduct
26VO2 peak up 12% (P < 0.05) after 8 weeks; endurance time up 23%Recreationally trained men, n = 9800 mg/day E. senticosus

26 11 12

↕

Time to exhaustion

Mixed results in trials

How long a person can keep exercising at a set hard effort.

Mixed findings
Results and what it means

Why it was measured

Measures performance.

Statistical vs. clinical meaning

One positive and two null trials.

Safety implication

Conflicting.

StudyResultPeopleProduct
26Endurance time improved 23% (P < 0.05)Recreationally trained men800 mg/day for 8 weeks
11No significant difference in time to exhaustion on a maximal treadmill testHighly trained runners3.4 mL extract/day for 6 weeks
1210-km time trial 18.10 vs 17.83 min, not significantTrained cyclists1,200 mg/day for 7 days

26 11 12

↕

Systolic blood pressure

Mixed results in trials

The top blood-pressure number.

Mixed findings
Results and what it means

Why it was measured

Linked to heart and stroke risk.

Statistical vs. clinical meaning

Different plant parts and people.

Safety implication

A small drop in healthy people does not show lower heart-attack or stroke risk.

StudyResultPeopleProduct
33Systolic pressure -7.7 vs +0.1 mmHg at the low fruit-extract dose (P = 0.044)Healthy adults with borderline risk factors500 mg/day A. senticosus FRUIT extract, 12 weeks
6No significant difference in blood pressure controlOlder adults on digitalis300 mg/day extract, 8 weeks

33 6

▲

Osteocalcin (bone-turnover marker)

Raised in trials

A blood protein made by bone-building cells.

Very low certainty
Results and what it means

Why it was measured

A marker of bone formation.

Statistical vs. clinical meaning

A marker, not bone strength.

Safety implication

None.

StudyResultPeopleProduct
20Higher than control at 6 months (P = 0.041)Postmenopausal women, n = 813 g/day extract plus calcium

20

●

Bone mineral density (DXA scan)

No clear change in trials

The amount of mineral in bone.

Low certainty
Results and what it means

Why it was measured

The main test for osteoporosis.

Statistical vs. clinical meaning

The clinical measure did not change.

Safety implication

None.

StudyResultPeopleProduct
20No significant changePostmenopausal women, n = 813 g/day extract plus calcium, 6 months

20

Safety

What studies and official sources say about side effects, medicines and who should check first. Each point shows what kind of evidence it comes from.

Main points to know 8
  • Buy only a product that names Eleutherococcus senticosus and the root: past mix-ups with Periploca (a heart-poison plant) and other species. An older case report describes a newborn with male-hormone (androgenising) effects after the mother took a product sold as 'pure Siberian ginseng'. The EMA assessment report says follow-up research found that product was adulterated with Periploca sepium, a plant that contains cardiac (heart-active) glycosides. The report also says a case of high digoxin in a man taking 'Siberian ginseng' may have been a mix-up with Periploca, because the product was never tested. These are old reports; no recent case of Periploca in a product was found in the sources read. In a 2018 DNA test of 25 UK Siberian ginseng supplements, all contained E. senticosus but 36% also contained another Eleutherococcus species. A 2023 review lists eleuthero root extract among botanicals at risk of adulteration. Case report 47 3 36 16 30
  • Heart medicine (digoxin): tell your doctor and the lab. One older man's digoxin blood level rose each time he took 'Siberian ginseng' and fell when he stopped, without signs of toxicity. The EMA report says this may be a lab-test artefact or a product mix-up. In the lab, some digoxin blood tests (FPIA and MEIA) read falsely high or low in the presence of some Siberian ginseng products; other tests showed no interference. A small trial of older people taking digoxin and Eleutherococcus extract found no change in digoxin level. In cells the extract may block a drug pump (P-glycoprotein), which could in theory raise digoxin levels. Evidence is low certainty, but anyone taking digoxin should tell their cardiologist and the lab before using it. Case report 30 7 8 9 42 6 47
  • Blood pressure and heart rhythm: sources disagree, so check with your doctor. Older guides said people with high blood pressure should avoid it. The EMA removed that warning in its 2014 review because the original study did not support it and later trials reported no rise in blood pressure. A 2012 review still lists Siberian ginseng among supplements associated with raised blood pressure, and the EMA monograph lists a fast heartbeat (tachycardia) as a possible effect, frequency not known. The trials we read in older adults showed no blood-pressure change. Authoritative guidance 47 48 35 6
  • Diabetes medicines: blood sugar may go up or down. In 12 healthy adults a dose of Siberian ginseng raised blood sugar after a sugar drink. In one exercise trial blood sugar was lower during cycling. LactMed says eleuthero may increase blood sugar, while the EMA report says medicines that lower blood sugar should be considered. No trial in people with diabetes was found. If you use insulin or diabetes pills, ask your doctor and check your blood sugar more often. Controlled trial 39 27 47
  • Blood thinners and bleeding. LactMed says eleuthero may increase bleeding. The EMA report says medicines that thin the blood should be considered, and cites a single multi-herb bleeding case in the brain (not attributed to eleuthero alone). A safety-centre chart review listed gut bleeding, nosebleed and vaginal bleeding in people who took Eleutherococcus with antidepressants. No controlled trial with warfarin or aspirin was found; a rat study of a Kan Jang mixture found no real warfarin effect (as reported by the EMA). Case report 27 40 47
  • Pregnancy, breastfeeding and children under 12: not recommended. The EU monograph says safety in pregnancy and breastfeeding has not been established and use is not recommended, and use under 12 is not recommended. LactMed says most sources recommend against use while breastfeeding because of missing safety data. Animal studies reported by the EMA found no birth defects, and old Russian reports on pregnant women are described as uncontrolled or poorly described. Authoritative guidance 48 27 47
  • Hormone-sensitive conditions: no good human data, so ask your doctor. In rat tissue the extract bound oestrogen and other hormone receptors in a lab test (as reported by the EMA), and in the chronic fatigue trial breast tenderness and uterine bleeding were more common on the extract (14% versus 4%, not a significant difference). LactMed also mentions breast tenderness. No study in breast, ovarian, uterine or prostate cancer, endometriosis or fibroids was found. The sensible position is to ask your doctor before use if you have a hormone-sensitive condition. Laboratory research 47 19 27
  • Sleep, mood and nerves. Insomnia, irritability and headache are listed in the EU monograph (frequency not known). The EMA report says insomnia can happen if it is taken too close to bedtime. If you have a mood disorder such as bipolar disorder, do not add any herb without your prescriber knowing. Authoritative guidance 48 47 44
Side effects 10
EffectHow oftenSeverity and recoveryEvidence
Insomnia (trouble sleeping)
Listed in the EU monograph; frequency not known. The EMA report says it may occur if taken too close to bedtime and cites 1966 studies in heart patients.
Not establishedmild
Presumed to ease after stopping
Authoritative guidance 48 47
Irritability, nervousness, anxiety
Listed in the EU monograph; the EMA report mentions irritability, melancholy and anxiety at higher doses in a 1966 study of 11 patients.
Not establishedmild
Presumed reversible
Authoritative guidance 48 47
Fast heartbeat (tachycardia), palpitations, shifts in rhythm
Listed in the EU monograph; in 1966 studies of heart patients (EMA report) some had heart rhythm shifts and extra beats. Frequency not known.
Not establishedmoderate
Presumed reversible
Authoritative guidance 48 47
Headache
Listed in the monograph; nervousness and headache were reported in the chronic-fatigue trial at similar rates on extract and placebo (EMA report).
Not establishedmild
Presumed reversible
Authoritative guidance 48 19
Breast tenderness and uterine bleeding
From the Hartz trial as reported in the EMA assessment; LactMed also notes breast tenderness.
14% on extract versus 4% on placebo in one trial (not significantly different)mild
Not stated
Controlled trial 19 47 27
Nausea, rash, diarrhoea
Adolescents on lithium plus the herb.
Nausea 2 of 37 (5.4%), rash 1 (2.7%), diarrhoea 1 (2.7%) in the herb group of one trialmild
Not stated
Controlled trial 44
Sleepiness, possible low blood sugar
The report says occasional sleepiness was seen in 1,500 athletes and was linked to a low-blood-sugar state; the original studies had no controls.
Occasional, per the EMA report on Soviet athlete studiesmild
Not stated
Case series 47
Allergic reactions (hives, swelling, anaphylaxis) with a mixed product
These reports are a count of spontaneous reports for a mixed product, not a rate. They also included raised liver enzymes and fever.
57 reports among 64,493 Swedish reports for an Echinacea, Eleutherococcus and Adhatoda productmoderate
Not stated
Case series 47
Bleeding (gut, nose, vaginal) with antidepressants
Duloxetine, paroxetine and sertraline cases in a chart review; cause is not proven.
Single reportsmoderate
Not stated
Case series 40
Raised blood pressure
2 of 55 rheumatic heart patients at high dose in a 1966 study (EMA report); a 2012 review lists it. The EMA removed the high-blood-pressure contraindication in 2014 for lack of support. Trials in older adults did not show a rise.
Not knownmoderate
Presumed reversible
Authoritative guidance 47 35
Liver

No LiverTox entry for eleuthero was found in a Bookshelf search (not fully proven; the LiverTox site itself could not be checked). The LactMed entry does not mention liver injury. The EMA report lists no laboratory findings and no serious events or deaths for oral root preparations. The only liver-related item found was in Swedish spontaneous reports for a mixed Echinacea, Eleutherococcus and Adhatoda product, which included raised liver enzymes (EMA report). No published human case of liver injury from eleuthero alone was found. 45 47 27

How often. No frequency of human liver injury was found. Not finding reports is not proof that none exist.

Monitoring. No agency monitoring advice was found. Stop and seek care for yellow skin or eyes, dark urine, pale stools or severe itching.

This is a safety connection. It is not evidence that Eleuthero supports liver health.

Medicines and supplements 11
WithWhy it mattersImportanceEvidenceWhat to do
Digoxin (blood levels)
prescription
Not settled. Possibilities: a true effect on elimination (the extract blocked P-glycoprotein in cells), a lab-test artefact, or a mix-up with a Periploca-contaminated product.One case report of a high level (no toxicity) that came and went with the herb; lab tests show interference with some digoxin assays; a small trial in 20 older people on digitalis (10 on the extract) found no change in level.Case report Low certainty 30 42 6 47If you take digoxin, tell your cardiologist before using eleuthero. Tell the lab which herb you take, since some tests misread it.
Digoxin blood tests (assay interference)
laboratory test
Plant compounds resemble digoxin in structure, so some antibody tests detect them.FPIA read falsely high and MEIA falsely low in the presence of some Siberian ginseng products; Digoxin III showed modest false highs; three other tests and the LOCI test showed no or negligible interference.Laboratory Moderate certainty 7 8 9Ask your lab which digoxin test they use if you take eleuthero.
Heart medicines and blood pressure drugs
prescription
Theory: the herb may change blood pressure or heart rate.The EMA report cites a textbook recommendation to consider interaction with drugs that affect blood pressure. A small trial found no change in blood pressure control in older adults on digitalis.Pharmacological theory Very low certainty 47 6Tell your doctor and check your blood pressure if you start it.
Diabetes medicines (insulin, metformin, sulfonylureas)
prescription
Theory: effects on blood sugar in both directions (raised in one test, lowered in another).LactMed says it may increase blood sugar; the EMA report says to consider medicines that lower sugar. No trial in diabetes.Pharmacological theory Very low certainty 39 27 47If you have diabetes, talk to your doctor and check blood sugar more often.
Blood thinners and antiplatelets (warfarin, aspirin, clopidogrel)
prescription
Theory only: LactMed and the EMA report both flag bleeding risk; a coumarin-containing multi-herb case is cited.No trial with warfarin was found. A rat study of a Kan Jang mixture with warfarin found practically no effect (EMA report).Pharmacological theory Very low certainty 27 47Tell the doctor managing your blood thinner; report unusual bleeding.
Antidepressants (SSRIs, SNRIs, agomelatine)
prescription
Possible additive effect on bleeding or on nerve signalling.Chart review: GI bleeding with duloxetine, nosebleed with paroxetine, vaginal bleeding with sertraline, agitation with agomelatine.Case report Very low certainty 40Tell your prescriber; report bleeding or agitation.
Drugs cleared by CYP2D6 or CYP3A4 (for example dextromethorphan, alprazolam)
prescription
Tested directly.No effect on either pathway in 12 healthy volunteers taking the extract for 14 days.Controlled trial Low certainty 10No change expected for these two pathways; other pathways were not tested.
Drugs cleared by CYP2C9 or CYP2E1
prescription
Weak enzyme inhibition by isolated eleutherosides in rat liver microsomes at high concentrations.Not tested in people.Laboratory research Very low certainty 18No action based on this alone.
Drugs moved by P-glycoprotein (digoxin and others)
prescription
The extract blocked P-glycoprotein and a peptide transporter in a human gut cell line.Not tested in people.Laboratory research Very low certainty 42 47Raise with your pharmacist if you take narrow-margin drugs.
Oestrogens, hormone therapy, hormone-blocking cancer medicines
prescription
The extract bound oestrogen receptors in rat uterus in a lab test (reported by EMA).No human data.Laboratory research Very low certainty 47Ask your doctor, especially in hormone-sensitive cancer.
Caffeine and other stimulants
non-prescription
Theory: insomnia, irritability and fast heartbeat are listed side effects, so effects may add up.No study found.Pharmacological theory Very low certainty 48Go easy on caffeine if you notice poor sleep or a racing heart.
Who should check first 10
SituationAdviceEvidence
Allergy to the plant or to Eleutherococcus productsDo not use. The EU monograph lists hypersensitivity to the active substance as the only contraindication; the EMA report cites WHO for hypersensitivity to Araliaceae family plants but found no literature showing general allergy across the family.Authoritative guidance 48 47
PregnancyNot recommended; safety not established.Authoritative guidance 48 47
BreastfeedingNot recommended; no data on nursing mothers or infants.Authoritative guidance 48 27
Children under 12Not recommended; lack of adequate data.Authoritative guidance 48
High blood pressureOlder guides said avoid; the EMA removed this contraindication in 2014. Ask your doctor and check your blood pressure.Authoritative guidance 47 35
Taking digoxin or other heart medicines, or heart rhythm problemsAsk your cardiologist first; tell the lab about it before digoxin tests.Case report 30 7 47
Diabetes or taking blood-sugar medicinesAsk your doctor and monitor sugar closely.Pharmacological theory 39 27
Taking blood thinners, or a bleeding disorder, or before surgeryAsk your doctor. LactMed says it may increase bleeding; the bleeding evidence is thin and mostly case reports.Pharmacological theory 27 40
Hormone-sensitive conditions (some breast, ovarian, uterine or prostate cancers, endometriosis, fibroids)Ask your doctor first; no human safety data.Laboratory research 47
Bipolar disorder or other mood disordersDo not add on your own; tell your prescriber.Case report 44 40
Overdose, product quality and regulators

Summary. Animal tests report very low acute toxicity for Eleutherococcus root extracts. No overdose case and no serious event or death from oral root preparations were found by the EMA. Clinical records in the 1960s to 1980s are old and uncontrolled.

Animal. The EMA report gives oral LD50 values in mice of about 30 g/kg for powdered root and about 14.5 g/kg for a 33% ethanol extract. It says toxic signs at very high doses (sedation, ataxia, tremor, vomiting) were thought to come more from the alcohol in the extract than from the plant. Rats given extracts at up to 400 mg/kg a day for 33 to 47 days showed no appreciable difference from controls.

Human doses studied. Trial doses ranged from short single doses to 8 weeks in healthy volunteers and patients; see the individual studies.

High dose or long term signals. The EMA report says side effects are more likely if normal doses are exceeded (herbal safety guide quoted) and that insomnia, irritability and palpitations were seen at higher doses in 1966 studies. The EU monograph limits the period of use (not for more than 2 months) and says to see a doctor if symptoms last longer than 2 weeks. Long-term safety beyond that was not found.

Overdose response. No case of overdose is reported (EU monograph).

Genotoxicity. Aqueous and ethanolic root extracts were negative in the Ames test (strains TA 100 and TA 98) and the mouse micronucleus test (EMA). The EMA notes adequate reproductive toxicity and carcinogenicity tests have not been done; it also notes one Ames strain was missing from the published test.

Toxic plant parts. No toxic part of E. senticosus was identified in the sources read. The root and rhizome are the traditional parts; leaf, stem and fruit products have separate and smaller safety records. The toxic-plant concern is a different plant: Periploca sepium, which the EMA report says contains cardiac (heart-active) glycosides.

The best-documented quality problems are mix-ups with other species. The historical Periploca mix-up involved a heart-active plant. In a modern DNA test, about one in three UK Siberian ginseng supplements contained another Eleutherococcus species as well. The European Pharmacopoeia sets a minimum content of eleutheroside B plus E for the root.

Periploca sepium found in a product sold as pure Siberian ginseng. The EMA report says a case of newborn male-hormone effects attributed to maternal use of 'pure Siberian ginseng' was traced to a product adulterated with Periploca sepium, and that the digoxin case may also have been a mix-up. Periploca sepium (GBIF key 5526185, family Apocynaceae) is a different plant from E. senticosus (family Araliaceae). The original 1996 letter could only be read as a title (no abstract). 47 3 50

Another Eleutherococcus species in supplements. Of 25 Siberian ginseng supplements tested by DNA barcoding in the UK, all contained E. senticosus but 36% also contained another Eleutherococcus species. 36

Eleuthero root listed as at risk of adulteration. A 2023 review of the American Botanical Council adulterants programme lists eleuthero root extract among botanical extracts at risk of adulteration. 16

Standard for the root. The EMA report states the European Pharmacopoeia requires dried root with at least 0.08% for the sum of eleutheroside B and eleutheroside E, and that products on the market do not always meet pharmacopoeial requirements. 47

Not true ginseng. LactMed says eleuthero is not related to true ginseng (Panax) and has different constituents. The EMA report says the US Ginseng Labelling Act of 2002 restricted the name 'Siberian ginseng' (this is second-hand; the law was not read). 27 47

BodyActionDate
European Medicines Agency, Committee on Herbal Medicinal Products (HMPC) (European Union)Community herbal monograph on Eleutherococcus senticosus root (EMA/HMPC/680618/2013): traditional herbal medicinal product, based on long use only, for symptoms of asthenia such as fatigue and weakness; adults and adolescents over 12. Contraindication: hypersensitivity. Pregnancy and breastfeeding not recommended. No interactions reported. Side effects: insomnia, irritability, tachycardia, headache. Not well-established use. source2014-03-25
European Medicines Agency, HMPC (assessment report and EU list entry) (European Union)Assessment report EMA/HMPC/680615/2013: clinical data inconclusive, none of the studies enough to prove efficacy in a defined condition; no specific safety concern; the contraindication 'arterial hypertension' was removed at the 5-year review; extracts are included in the EU list of traditional herbal substances; a second review call for data closed 31 May 2025. source2014-03-25
LactMed (US National Library of Medicine) (United States)Eleuthero entry (updated 15 Sep 2024): no data for nursing mothers or infants; may increase blood pressure, bleeding and blood sugar; breast tenderness reported; most sources advise against use while breastfeeding. source2024-09-15
When to get medical help
  • Chest pain, a very fast or irregular heartbeat with dizziness or fainting: call emergency services. Do not wait.
  • Swelling of the face, lips or tongue, hives, or trouble breathing after taking it: call emergency services (allergic reaction).
  • Black or bloody stools, vomiting blood, a nosebleed that will not stop, or heavy unexpected vaginal bleeding, especially if you take blood thinners or antidepressants: seek urgent care.
  • If you take digoxin: nausea, vomiting, blurred or yellow-tinged vision, or a very slow pulse: seek urgent care (these are signs of too much digoxin, whatever the cause).
  • Shakiness, sweating and confusion if you take diabetes medicines (possible low blood sugar): treat with sugar and seek care.
  • Yellow skin or eyes, dark urine or pale stools: stop it and see a doctor.
  • Severe headache with very high blood pressure readings: seek urgent care.
  • A newborn or infant with unusual symptoms after the mother used a product sold as Siberian ginseng: tell the paediatrician about the product.

Stop the supplement and contact a clinician or emergency service. In the US, Poison Control is 1-800-222-1222.

General information only, not medical advice. Ask a clinician or pharmacist before use, especially with medicines, in pregnancy or with a health condition. See the Natural Remedy Safety guide.

Frequently asked questions

What is eleuthero?

Eleuthero (Eleutherococcus senticosus) is a woody shrub from Northeast Asia in the same plant family as true ginseng. Its root is the part used in medicine. It is also called Siberian ginseng, but it is a different plant from Asian or American ginseng.

49 51 27 25

Does eleuthero fight tiredness?

Probably not much, and the evidence is weak. One trial of 96 people with long-lasting tiredness found no difference from placebo overall. The EU allows it as a traditional medicine for tiredness and weakness based on long use, but the EU's own review says none of the studies is enough to prove it works.

19 47 48 34

Does it help with stress or burnout?

Not shown. A German trial of 144 people found that adding root extract to a stress-management course made no real difference. A burnout trial with a four-ingredient product cannot be credited to eleuthero.

38 21

Can it improve sports performance?

The results conflict. Two small trials in trained athletes found no benefit, and one trial of 9 men found better endurance. All were small, so athletes should not count on it.

11 12 26

Does it lower or raise blood sugar?

No one knows. It raised blood sugar after a sugar drink in 12 healthy people, and lowered it in one exercise trial. No trial in people with diabetes was found. If you take diabetes medicine, talk to your doctor first.

39 26 27

Is eleuthero safe for people with high blood pressure or heart problems?

Sources disagree. Older guides said to avoid it in high blood pressure, but the EU removed that warning in 2014 because it was not supported by trials. A review still lists it among supplements linked to higher blood pressure, and the EU lists a fast heartbeat as a possible side effect. If you have high blood pressure or a heart condition, check with your doctor first.

47 35 48 6

Can I take it with digoxin or other heart medicines?

Ask your cardiologist first. One man's digoxin blood level rose each time he took a Siberian ginseng product, but the product was never tested and may have been mixed up with another plant. Some lab tests for digoxin also misread certain Siberian ginseng products. A small trial of older people on digitalis found no change in digoxin level.

30 7 8 9 6 47

What is the Periploca problem?

In the past, at least one product sold as 'pure Siberian ginseng' was found to contain Periploca sepium, a different plant with heart-active compounds. The EU assessment links this to a newborn case and says it may explain a digoxin case. In a 2018 test, 36% of UK Siberian ginseng supplements contained another Eleutherococcus species. Choose products that name Eleutherococcus senticosus and the root and are tested by an independent lab.

47 3 36 16

Can I take it with blood thinners or antidepressants?

Talk to your doctor or pharmacist. LactMed says it may increase bleeding, and a chart review listed bleeding in people who took it with some antidepressants. No controlled trial with blood thinners was found.

27 40 47

What are the side effects?

The EU monograph lists trouble sleeping, irritability, fast heartbeat and headache, with the frequency not known. Taken close to bedtime it may disturb sleep. Breast tenderness and uterine bleeding were more common on the extract in one trial, but the difference was not statistically significant. One mixed product was linked to allergic reactions in spontaneous reports.

48 47 19 27

Is it safe in pregnancy, breastfeeding or for children?

Not recommended. The EU monograph says safety in pregnancy and breastfeeding has not been established and use under age 12 is not recommended. LactMed says most sources advise against it while breastfeeding.

48 27

Is it safe if I have a hormone-sensitive condition?

There is no good human data. In a lab test it bound oestrogen receptors in rat tissue. If you have a hormone-sensitive condition such as some breast, ovarian, uterine or prostate cancers, ask your doctor first.

47 19

Explore by health goal

Reduce FatigueImmune SupportStress ReductionHealthy AgingResilience SupportCognitive PerformanceWomens WellnessEnergy BoostBurnout RecoveryBetter FocusMental ClarityMemory SupportMood BalanceAdrenal SupportEndurance SupportPhysical StaminaPeak PerformanceInflammation BalanceBlood Sugar BalanceMetabolic HealthBlood Pressure SupportHeart HealthCholesterol BalanceMenopause SupportDigestive SupportHealthy SkinLibido Support

Editorial transparency
Written by
AlternativeMed editorial team. Research compiled with AI assistance, then checked against PubMed records.
Medical review
None. This page has not been reviewed by a physician or pharmacist.
First published
2026-10-25
Last substantive update
2026-10-25
How we research
We searched PubMed, the EU herbal monograph and assessment report, LactMed and other regulators' pages, and recorded each study's design, people, product and result as reported. Only abstracts were read for most studies; the EU documents were read in full. Some sources (the original 1996 Awang letter beyond its title, Commission E, WHO, ESCOP, FDA, NCCIH and LiverTox) could not be read and are marked not verified or not found. Certainty ratings for many uses are the compiler's own reading, not formal grades. No study is cited that we could not verify.
How we rate evidence
See "How we rate evidence" in the Evidence tab.
Independence
No product is promoted on this page. No affiliate links are shown. If one is added later it will be labelled and kept apart from the evidence.
Sources 53

Each source was opened and checked. Where we read only the abstract, it says so. The small numbers in the text point here.

  1. Amaryan G, Astvatsatryan V, Gabrielyan E et al.. Double-blind, placebo-controlled, randomized, pilot clinical trial of ImmunoGuard--a standardized fixed combination of Andrographis paniculata Nees, with Eleutherococcus senticosus Maxim, Schizandra chinensis Bail. and Glycyrrhiza glabra L. extracts in patients with Familial Mediterranean Fever.. Phytomedicine. 2003. PMID 12809357. DOI 10.1078/094471103322004767. (abstract)
  2. Aslanyan G, Amroyan E, Gabrielyan E et al.. Double-blind, placebo-controlled, randomised study of single dose effects of ADAPT-232 on cognitive functions.. Phytomedicine. 2010. PMID 20374974. DOI 10.1016/j.phymed.2010.02.005. (abstract)
  3. Awang DV. Siberian ginseng toxicity may be case of mistaken identity.. CMAJ. 1996. PMID 8964001. (title-only)
  4. Bang JS, Chung YH, Chung SJ et al.. Clinical effect of a polysaccharide-rich extract of Acanthopanax senticosus on alcohol hangover.. Pharmazie. 2015. PMID 26012258. (abstract)
  5. Barth A, Hovhannisyan A, Jamalyan K et al.. Antitussive effect of a fixed combination of Justicia adhatoda, Echinacea purpurea and Eleutherococcus senticosus extracts in patients with acute upper respiratory tract infection: A comparative, randomized, double-blind, placebo-controlled study.. Phytomedicine. 2015. PMID 26598919. DOI 10.1016/j.phymed.2015.10.001. (abstract)
  6. Cicero AF, Derosa G, Brillante R et al.. Effects of Siberian ginseng (Eleutherococcus senticosus maxim.) on elderly quality of life: a randomized clinical trial.. Arch Gerontol Geriatr Suppl. 2004. PMID 15207399. DOI 10.1016/j.archger.2004.04.012. (abstract)
  7. Dasgupta A, Wu S, Actor J et al.. Effect of Asian and Siberian ginseng on serum digoxin measurement by five digoxin immunoassays. Significant variation in digoxin-like immunoreactivity among commercial ginsengs.. Am J Clin Pathol. 2003. PMID 12580002. DOI 10.1309/34BJ-ECP7-UK6F-H13V. (abstract)
  8. Dasgupta A, Tso G, Wells A. Effect of Asian ginseng, Siberian ginseng, and Indian ayurvedic medicine Ashwagandha on serum digoxin measurement by Digoxin III, a new digoxin immunoassay.. J Clin Lab Anal. 2008. PMID 18623124. DOI 10.1002/jcla.20252. (abstract)
  9. Dasgupta A, Syklawer E, Johnson M et al.. Effect of Chinese medicines Chan Su, Asian ginseng, Siberian ginseng, and American ginseng on a new digoxin immunoassay based on luminescent oxygen channeling technology.. Ther Drug Monit. 2011. PMID 21860344. DOI 10.1097/FTD.0b013e3182252103. (abstract)
  10. Donovan JL, DeVane CL, Chavin KD et al.. Siberian ginseng (Eleutheroccus senticosus) effects on CYP2D6 and CYP3A4 activity in normal volunteers.. Drug Metab Dispos. 2003. PMID 12695337. DOI 10.1124/dmd.31.5.519. (abstract)
  11. Dowling EA, Redondo DR, Branch JD et al.. Effect of Eleutherococcus senticosus on submaximal and maximal exercise performance.. Med Sci Sports Exerc. 1996. PMID 8778554. DOI 10.1097/00005768-199604000-00013. (abstract)
  12. Eschbach LF, Webster MJ, Boyd JC et al.. The effect of siberian ginseng (Eleutherococcus senticosus) on substrate utilization and performance.. Int J Sport Nutr Exerc Metab. 2000. PMID 11099371. DOI 10.1123/ijsnem.10.4.444. (abstract)
  13. Fukada K, Kajiya-Sawane M, Matsumoto Y et al.. Antiedema effects of Siberian ginseng in humans and its molecular mechanism of lymphatic vascular function in vitro.. Nutr Res. 2016. PMID 27333960. DOI 10.1016/j.nutres.2016.02.012. (abstract)
  14. Gaffney BT, Hügel HM, Rich PA. The effects of Eleutherococcus senticosus and Panax ginseng on steroidal hormone indices of stress and lymphocyte subset numbers in endurance athletes.. Life Sci. 2001. PMID 11798012. DOI 10.1016/s0024-3205(01)01394-7. (abstract)
  15. Gaffney BT, Hügel HM, Rich PA. Panax ginseng and Eleutherococcus senticosus may exaggerate an already existing biphasic response to stress via inhibition of enzymes which limit the binding of stress hormones to their receptors.. Med Hypotheses. 2001. PMID 11388770. DOI 10.1054/mehy.2000.1163. (abstract)
  16. Gafner S, Blumenthal M, Foster S et al.. Botanical Ingredient Forensics: Detection of Attempts to Deceive Commonly Used Analytical Methods for Authenticating Herbal Dietary and Food Ingredients and Supplements.. J Nat Prod. 2023. PMID 36716213. DOI 10.1021/acs.jnatprod.2c00929. (abstract)
  17. Ghamari K, Kashani L, Jafarinia M et al.. Vitamin E and ginseng supplementation to enhance female sexual function: a randomized, double-blind, placebo-controlled, clinical trial.. Women Health. 2020. PMID 32893745. DOI 10.1080/03630242.2020.1803465. (abstract)
  18. Guo S, Liu Y, Lin Z et al.. Effects of eleutheroside B and eleutheroside E on activity of cytochrome P450 in rat liver microsomes.. BMC Complement Altern Med. 2014. PMID 24383621. DOI 10.1186/1472-6882-14-1. (abstract)
  19. Hartz AJ, Bentler S, Noyes R et al.. Randomized controlled trial of Siberian ginseng for chronic fatigue.. Psychol Med. 2004. PMID 14971626. DOI 10.1017/s0033291703008791. (abstract)
  20. Hwang YC, Jeong IK, Ahn KJ et al.. The effects of Acanthopanax senticosus extract on bone turnover and bone mineral density in Korean postmenopausal women.. J Bone Miner Metab. 2009. PMID 19452124. DOI 10.1007/s00774-009-0093-3. (abstract)
  21. Jacquet A, Grolleau A, Jove J et al.. Burnout: evaluation of the efficacy and tolerability of TARGET 1® for professional fatigue syndrome (burnout).. J Int Med Res. 2015. PMID 25537278. DOI 10.1177/0300060514558324. (abstract)
  22. Jia A, Zhang Y, Gao H et al.. A review of Acanthopanax senticosus (Rupr and Maxim.) harms: From ethnopharmacological use to modern application.. J Ethnopharmacol. 2021. PMID 33212178. DOI 10.1016/j.jep.2020.113586. (abstract)
  23. Kaloeva ZD. [Effect of the glycosides of Eleutherococcus senticosus on the hemodynamic indices of children with hypotensive states].. Farmakol Toksikol. 1986. PMID 3770180. (abstract)
  24. Kawano Y, Watanabe N, Nishiyama M et al.. Feasibility and Safety of Food Containing Acanthopanax senticosus for Treating Patients with Cancer-Related Fatigue.. Palliat Med Rep. 2024. PMID 39281184. DOI 10.1089/pmr.2024.0041. (abstract)
  25. Kos G, Czarnek K, Sadok I et al.. Eleutherococcus senticosus (Acanthopanax senticosus): An Important Adaptogenic Plant.. Molecules. 2025. PMID 40572479. DOI 10.3390/molecules30122512. (abstract)
  26. Kuo J, Chen KW, Cheng IS et al.. The effect of eight weeks of supplementation with Eleutherococcus senticosus on endurance capacity and metabolism in human.. Chin J Physiol. 2010. PMID 21793317. DOI 10.4077/cjp.2010.amk018. (abstract)
  27. LactMed (NLM/NICHD). Eleuthero.. Drugs and Lactation Database (LactMed), NICHD. 2024. PMID 30000865. (abstract)
  28. Lau KM, Yue GG, Chan YY et al.. A review on the immunomodulatory activity of Acanthopanax senticosus and its active components.. Chin Med. 2019. PMID 31388349. DOI 10.1186/s13020-019-0250-0. (abstract)
  29. Li XT, Zhou JC, Zhou Y et al.. Pharmacological effects of Eleutherococcus senticosus on the neurological disorders.. Phytother Res. 2022. PMID 35844057. DOI 10.1002/ptr.7555. (abstract)
  30. McRae S. Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng.. CMAJ. 1996. PMID 8705908. (abstract)
  31. Narimanian M, Badalyan M, Panosyan V et al.. Randomized trial of a fixed combination (KanJang) of herbal extracts containing Adhatoda vasica, Echinacea purpurea and Eleutherococcus senticosus in patients with upper respiratory tract infections.. Phytomedicine. 2005. PMID 16121513. DOI 10.1016/j.phymed.2004.10.001. (abstract)
  32. Narimanian M, Badalyan M, Panosyan V et al.. Impact of Chisan (ADAPT-232) on the quality-of-life and its efficacy as an adjuvant in the treatment of acute non-specific pneumonia.. Phytomedicine. 2005. PMID 16323290. DOI 10.1016/j.phymed.2004.11.004. (abstract)
  33. Oh E, Kim Y, Park SY et al.. The fruit of Acanthopanax senticosus Harms improves arterial stiffness and blood pressure: a randomized, placebo-controlled trial.. Nutr Res Pract. 2020. PMID 32765813. DOI 10.4162/nrp.2020.14.4.322. (abstract)
  34. Patyra A, Kołtun-Jasion M, Kupniewska K et al.. Eleutherococcus root: a comprehensive review of its phytochemistry and pharmacological potential in the context of its adaptogenic effect.. Front Pharmacol. 2025. PMID 41235111. DOI 10.3389/fphar.2025.1683795. (abstract)
  35. Rasmussen CB, Glisson JK, Minor DS. Dietary supplements and hypertension: potential benefits and precautions.. J Clin Hypertens (Greenwich). 2012. PMID 22747620. DOI 10.1111/j.1751-7176.2012.00642.x. (abstract)
  36. Ruhsam M, Hollingsworth PM. Authentication of Eleutherococcus and Rhodiola herbal supplement products in the United Kingdom.. J Pharm Biomed Anal. 2018. PMID 29154110. DOI 10.1016/j.jpba.2017.11.025. (abstract)
  37. Sato T, Aoki T, Ito Y et al.. Effects of continuous supplementation of Acanthopanax senticosus Harms on the cardiac autonomic function of community-dwelling elderly individuals during resting and standing tests: a randomized controlled trial.. Front Cardiovasc Med. 2024. PMID 38525193. DOI 10.3389/fcvm.2024.1336676. (abstract)
  38. Schaffler K, Wolf OT, Burkart M. No benefit adding eleutherococcus senticosus to stress management training in stress-related fatigue/weakness, impaired work or concentration, a randomized controlled study.. Pharmacopsychiatry. 2013. PMID 23740477. DOI 10.1055/s-0033-1347178. (abstract)
  39. Sievenpiper JL, Arnason JT, Leiter LA et al.. Decreasing, null and increasing effects of eight popular types of ginseng on acute postprandial glycemic indices in healthy humans: the role of ginsenosides.. J Am Coll Nutr. 2004. PMID 15190050. DOI 10.1080/07315724.2004.10719368. (abstract)
  40. Siwek M, Woroń J, Wrzosek A et al.. Harder, better, faster, stronger? Retrospective chart review of adverse events of interactions between adaptogens and antidepressant drugs.. Front Pharmacol. 2023. PMID 37829299. DOI 10.3389/fphar.2023.1271776. (abstract)
  41. Szołomicki J, Samochowiec L, Wójcicki J et al.. The influence of active components of Eleutherococcus senticosus on cellular defence and physical fitness in man.. Phytother Res. 2000. PMID 10641044. DOI 10.1002/(sici)1099-1573(200002)14:1<30::aid-ptr543>3.3.co;2-m. (abstract)
  42. Takahashi T, Kaku T, Sato T et al.. Effects of Acanthopanax senticosus HARMS extract on drug transport in human intestinal cell line Caco-2.. J Nat Med. 2010. PMID 20091240. DOI 10.1007/s11418-009-0371-3. (abstract)
  43. Tohda C, Matsui M, Inada Y et al.. Combined Treatment with Two Water Extracts of Eleutherococcus senticosus Leaf and Rhizome of Drynaria fortunei Enhances Cognitive Function: A Placebo-Controlled, Randomized, Double-Blind Study in Healthy Adults.. Nutrients. 2020. PMID 31979283. DOI 10.3390/nu12020303. (abstract)
  44. Weng S, Tang J, Wang G et al.. Comparison of the Addition of Siberian Ginseng (Acanthopanax senticosus) Versus Fluoxetine to Lithium for the Treatment of Bipolar Disorder in Adolescents: A Randomized, Double-Blind Trial.. Curr Ther Res Clin Exp. 2007. PMID 24683218. DOI 10.1016/j.curtheres.2007.08.004. (abstract)
  45. . NCBI Bookshelf search for a LiverTox entry on eleuthero / Eleutherococcus. . . (search)
  46. . EMA herbal medicine page: Eleutherococci radix. . . (full-text)
  47. . EMA/HMPC Assessment report on Eleutherococcus senticosus (Rupr. et Maxim.) Maxim., radix (EMA/HMPC/680615/2013). . . (full-text)
  48. . EMA/HMPC Community herbal monograph on Eleutherococcus senticosus (Rupr. et Maxim.) Maxim., radix (EMA/HMPC/680618/2013), 25 March 2014. . . (full-text)
  49. . GBIF Backbone: Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. (usageKey 3035369). . . (api)
  50. . GBIF Backbone: Periploca sepium Bunge (usageKey 5526185). . . (api)
  51. . NCBI Taxonomy: Eleutherococcus senticosus (taxid 82096). . . (api)
  52. . NCCIH: no eleuthero or Siberian ginseng health page found. . . (search)
  53. . PubChem compound records: syringin, eleutheroside E, isofraxidin, chlorogenic acid, sesamin, beta-hederin, sitogluside, coniferaldehyde. . . (api)

Where to buy

Check the label first. Whatever you buy, look for these:

  • The plant part and extract type
  • A third-party testing mark (USP, NSF or ConsumerLab)
  • Other ingredients and fillers
  • Interactions: ask a pharmacist if you take medicines, are pregnant or have a thyroid condition

Talk to a pharmacist or doctor before you start any supplement, especially if you take medicines. See the Safety tab for interactions.

Browse Eleuthero on Amazon
Amazon · Several brands to compare
Shop Eleuthero on Amazon

Support our free guides: as an Amazon Associate we earn from qualifying purchases. Full disclosure.

Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.